https://pharmadispatch.com/news/time-to-confront-finance-over-ongoing-pbs-attacks 2018-01-15T17:00:01+11:00 https://pharmadispatch.com/news/a-special-place-for-nicotine-patches-in-pbs-history 2018-01-15T17:00:01+11:00 https://pharmadispatch.com/news/cabinet-papers-reveal-origin-of-deferrals-policy 2018-01-15T17:00:01+11:00 https://pharmadispatch.com/news/vale-donna-staunton 2018-01-08T17:00:01+11:00 https://pharmadispatch.com/news/finance-met-with-pharmac 2018-01-16T17:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-secures-another-milestone-payment 2018-01-15T17:00:01+11:00 https://pharmadispatch.com/news/approval-for-another-pd-l1-inhibitor 2018-01-15T17:00:01+11:00 https://pharmadispatch.com/news/neuclone-adds-fifth-biosimilar-candidate-to-portfolio 2018-01-15T17:00:01+11:00 https://pharmadispatch.com/news/pfizers-journey-to-the-sydney-cbd 2018-01-17T17:00:01+11:00 https://pharmadispatch.com/news/hospitals-take-increasing-share-of-pbs-spend 2018-01-16T17:00:01+11:00 https://pharmadispatch.com/news/ma-executive-moving-to-devices 2018-01-16T17:00:01+11:00 https://pharmadispatch.com/news/msd-welcomes-new-keytruda-approval-1 2018-01-16T17:00:01+11:00 https://pharmadispatch.com/news/pharmac-australia-harming-cancer-patients 2018-01-18T05:00:01+11:00 https://pharmadispatch.com/news/even-senate-denied-rebate-forecast 2018-01-17T17:00:01+11:00 https://pharmadispatch.com/news/fda-approves-next-step-for-qimr-berghofer-developed-immunotherap 2018-01-17T17:00:01+11:00 https://pharmadispatch.com/news/accuracy-the-issue-when-it-comes-to-rebates 2018-01-18T17:00:01+11:00 https://pharmadispatch.com/news/trial-shows-msds-keytruda-extends-lung-cancer-survival 2018-01-18T17:00:01+11:00 https://pharmadispatch.com/news/orphan-designation-for-benitec-gene-therapy 2018-01-18T17:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-rejects-pharmac-claim 2018-01-18T17:00:01+11:00 https://pharmadispatch.com/news/tga-sticks-with-same-names-for-biologics 2018-01-19T17:00:01+11:00 https://pharmadispatch.com/news/no-answer-on-contingency-reserve 2018-01-19T17:00:01+11:00 https://pharmadispatch.com/news/turnbull-optimistic-on-pacific-trade-pact 2018-01-19T17:00:01+11:00 https://pharmadispatch.com/news/servier-advancing-local-cancer-discovery 2018-01-19T17:00:01+11:00 https://pharmadispatch.com/news/exclusive-government-moving-on-rebates 2018-01-22T17:00:01+11:00 https://pharmadispatch.com/news/department-reveals-more-on-deeds 2018-01-22T17:00:01+11:00 https://pharmadispatch.com/news/an-change-with-very-serious-implications 2018-01-22T17:00:01+11:00 https://pharmadispatch.com/news/new-regional-leadership-for-gsk-consumer-health 2018-01-22T17:00:01+11:00 https://pharmadispatch.com/news/department-reveals-medicines-not-yet-listed 2018-01-23T17:00:01+11:00 https://pharmadispatch.com/news/mixed-views-on-proposed-rebate-change 2018-01-23T17:00:01+11:00 https://pharmadispatch.com/news/pbac-to-consider-whooping-cough-vaccines-in-march 2018-01-24T05:00:01+11:00 https://pharmadispatch.com/news/sanofi-acquires-bioverativ-for-us116bn 2018-01-23T17:00:01+11:00 https://pharmadispatch.com/news/bms-welcomes-new-orencia-indication 2018-01-23T17:00:01+11:00 https://pharmadispatch.com/news/ma-confirms-pre-christmas-rebate-discussions 2018-01-24T17:00:01+11:00 https://pharmadispatch.com/news/the-facts-on-consumer-health-spending 2018-01-24T17:00:01+11:00 https://pharmadispatch.com/news/approval-for-ipsens-kidney-cancer-therapy 2018-01-24T17:00:01+11:00 https://pharmadispatch.com/news/ip-provisions-suspended-but-not-scrapped 2018-01-24T17:00:01+11:00 https://pharmadispatch.com/news/gsk-and-jj-top-antimicrobial-resistance-benchmark 2018-01-24T17:00:01+11:00 https://pharmadispatch.com/news/the-supply-chain-challenge-for-rebate-change 2018-01-25T17:00:01+11:00 https://pharmadispatch.com/news/new-appointment-for-industry-nominated-pbac-member 2018-01-25T17:00:01+11:00 https://pharmadispatch.com/news/contracts-can-be-a-wonderful-thing 2018-01-25T17:00:01+11:00 https://pharmadispatch.com/news/rare-cancers-welcomes-funding-commitment 2018-01-25T17:00:01+11:00 https://pharmadispatch.com/news/major-change-in-greg-hunts-office 2018-01-29T17:00:01+11:00 https://pharmadispatch.com/news/government-seeking-compact-with-rare-disease-companies 2018-01-29T17:00:01+11:00 https://pharmadispatch.com/news/any-saving-is-small-and-may-not-even-stay-in-the-pbs 2018-01-29T17:00:01+11:00 https://pharmadispatch.com/news/australia-day-recognition-for-pbac-member 2018-01-29T17:00:01+11:00 https://pharmadispatch.com/news/is-industry-already-on-the-hook-for-savings 2018-01-29T17:00:01+11:00 https://pharmadispatch.com/news/complex-hardly-describes-rebate-proposals 2018-01-29T20:42:01+11:00 https://pharmadispatch.com/news/department-set-to-present-cost-recovery-changes 2018-01-31T16:00:01+11:00 https://pharmadispatch.com/news/no-gst-on-scripts-a-concession 2018-01-30T17:00:01+11:00 https://pharmadispatch.com/news/new-report-highlight-incidence-and-impact-of-diabetes 2018-01-30T17:00:01+11:00 https://pharmadispatch.com/news/sun-pharma-seeks-support-for-adrenaline-a-flag 2018-01-30T17:00:01+11:00 https://pharmadispatch.com/news/sanofi-welcomes-new-registration 2018-01-30T17:00:01+11:00 https://pharmadispatch.com/news/not-all-happy-about-lsdp-outcome 2018-01-31T16:00:01+11:00 https://pharmadispatch.com/news/report-recommends-cap-on-rd-tax-incentive-payments 2018-01-31T16:00:01+11:00 https://pharmadispatch.com/news/us-based-company-to-acquire-sirtex 2018-01-31T16:00:01+11:00 https://pharmadispatch.com/news/what-about-pbs-co-payments 2018-02-01T16:00:01+11:00 https://pharmadispatch.com/news/australian-scientist-wins-japanese-prize 2018-02-01T16:00:01+11:00 https://pharmadispatch.com/news/trump-right-to-try 2018-02-01T16:00:01+11:00 https://pharmadispatch.com/news/ma-seeking-clarity-on-rd-tax-incentive 2018-02-01T16:00:01+11:00 https://pharmadispatch.com/news/new-medicines-nz-chair-calls-for-change 2018-02-02T16:00:01+11:00 https://pharmadispatch.com/news/celgene-welcomes-updated-revlimid-listing 2018-02-02T16:00:01+11:00 https://pharmadispatch.com/news/launching-pharmadispatch-conference-what-future-the-pbs 2018-02-02T16:00:01+11:00 https://pharmadispatch.com/news/sector-backs-political-process-1 2018-02-02T16:00:01+11:00 https://pharmadispatch.com/news/rare-cancer-patients-an-ignored-group 2018-02-05T16:00:01+11:00 https://pharmadispatch.com/news/allcan-launches-in-australia 2018-02-05T16:00:01+11:00 https://pharmadispatch.com/news/companies-not-embracing-rebate-change 2018-02-05T16:00:01+11:00 https://pharmadispatch.com/news/sector-right-to-be-nervous-and-cynical 2018-02-05T16:00:01+11:00 https://pharmadispatch.com/news/new-pbs-adviser-for-greg-hunt 2018-02-05T16:00:01+11:00 https://pharmadispatch.com/news/companies-await-cost-recovery-changes 2018-02-06T16:00:01+11:00 https://pharmadispatch.com/news/pbs-cost-recovery-is-not-cost-recovery-at-all 2018-02-06T16:00:01+11:00 https://pharmadispatch.com/news/labor-to-back-provisional-approval-bill 2018-02-06T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-launches-ceo-survey 2018-02-06T16:00:01+11:00 https://pharmadispatch.com/news/labor-to-back-provisional-approval-bill-1 2018-02-06T16:00:01+11:00 https://pharmadispatch.com/news/regional-leadership-for-ex-merck-australia-boss 2018-02-07T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-innovation-report-underwhelming 2018-02-07T16:00:01+11:00 https://pharmadispatch.com/news/toughest-job-in-australian-industry 2018-02-07T16:00:01+11:00 https://pharmadispatch.com/news/companies-baulk-at-july-implementation 2018-02-08T16:00:01+11:00 https://pharmadispatch.com/news/allergan-acquires-australian-company 2018-02-08T16:00:01+11:00 https://pharmadispatch.com/news/guild-focus-shifts-to-prescription-codeine 2018-02-08T16:00:01+11:00 https://pharmadispatch.com/news/more-conference-speakers-confirmed 2018-02-08T16:00:01+11:00 https://pharmadispatch.com/news/new-indication-for-lundbecks-abilify-maintena 2018-02-08T16:00:01+11:00 https://pharmadispatch.com/news/labor-all-savings-must-be-reinvested-in-new-medicines 2018-02-08T16:00:01+11:00 https://pharmadispatch.com/news/msd-calls-out-rivals-for-fight4thepharmacup 2018-02-09T16:00:01+11:00 https://pharmadispatch.com/news/industry-facing-massive-increase-in-fees 2018-02-09T16:00:01+11:00 https://pharmadispatch.com/news/health-debate-heating-up 2018-02-09T16:00:01+11:00 https://pharmadispatch.com/news/should-industry-fund-inefficient-processes 2018-02-09T16:00:01+11:00 https://pharmadispatch.com/news/exclusive-pba-asked-to-mandate-biosimilars-for-new-patients 2018-02-12T16:00:01+11:00 https://pharmadispatch.com/news/government-guidelines-require-consulting-not-informing 2018-02-12T16:00:01+11:00 https://pharmadispatch.com/news/prep-listing-will-come-down-to-price 2018-02-12T16:00:01+11:00 https://pharmadispatch.com/news/jobs-and-exports-grew-in-2016 2018-02-12T16:00:01+11:00 https://pharmadispatch.com/news/us-price-reform-but-no-direct-negotiation 2018-02-12T16:00:01+11:00 https://pharmadispatch.com/news/another-busy-pre-budget-period-for-industry 2018-02-13T16:00:01+11:00 https://pharmadispatch.com/news/new-report-says-countries-pay-more-or-no-access-in-the-us 2018-02-13T16:00:01+11:00 https://pharmadispatch.com/news/the-cost-recovery-rules-could-not-be-clearer 2018-02-13T16:00:01+11:00 https://pharmadispatch.com/news/funds-building-for-mt-kosciuszko-challenge 2018-02-13T16:00:01+11:00 https://pharmadispatch.com/news/funding-activity-or-a-revenue-target 2018-02-13T16:00:01+11:00 https://pharmadispatch.com/news/sigma-partners-with-medibank 2018-02-13T16:00:01+11:00 https://pharmadispatch.com/news/constructive-dialogue-required-to-modernise-system 2018-02-16T16:00:01+11:00 https://pharmadispatch.com/news/how-will-companies-respond-to-pbs-price-changes 2018-02-14T16:00:01+11:00 https://pharmadispatch.com/news/sector-welcomes-passage-of-reform-bill 2018-02-14T16:00:01+11:00 https://pharmadispatch.com/news/us-drug-pricing-reform-proposals 2018-02-14T16:00:01+11:00 https://pharmadispatch.com/news/fight-on-cost-recovery-to-save-agreements 2018-02-15T16:00:01+11:00 https://pharmadispatch.com/news/hunt-part-of-the-same-business 2018-02-15T16:00:01+11:00 https://pharmadispatch.com/news/australia-must-walk-the-talk-on-innovation 2018-02-15T16:00:01+11:00 https://pharmadispatch.com/news/terry-white-group-confident-of-stronger-growth 2018-02-15T16:00:01+11:00 https://pharmadispatch.com/news/companies-considering-lsdp-compact 2018-02-16T16:00:01+11:00 https://pharmadispatch.com/news/arthritis-researcher-recognised-with-medicines-new-zealand-award 2018-02-16T16:00:01+11:00 https://pharmadispatch.com/news/industry-facing-pressure-to-accept-rebate-change 2018-02-16T16:00:01+11:00 https://pharmadispatch.com/news/gsk-and-viiv-seek-to-pull-back-the-curtain-on-pbs 2018-02-16T16:00:01+11:00 https://pharmadispatch.com/news/pbac-hits-pan-tumour-roadblock 2018-02-19T16:00:01+11:00 https://pharmadispatch.com/news/top-employer-status-for-takeda-australia 2018-02-19T16:00:01+11:00 https://pharmadispatch.com/news/msac-back-pdl1-biomarker-test 2018-02-18T22:35:01+11:00 https://pharmadispatch.com/news/hcv-eradication-at-risk-as-uptake-plummets 2018-02-19T16:00:01+11:00 https://pharmadispatch.com/news/vertex-drops-french-trials-but-sticks-with-australia 2018-02-19T16:00:01+11:00 https://pharmadispatch.com/news/government-confirms-stronger-flu-vaccines-for-nip 2018-02-19T16:00:01+11:00 https://pharmadispatch.com/news/mundipharma-acquires-tolmar-australia 2018-02-19T23:49:01+11:00 https://pharmadispatch.com/news/where-are-the-missing-patients 2018-02-20T16:00:01+11:00 https://pharmadispatch.com/news/pfizer-backs-patient-hackathon 2018-02-20T16:00:01+11:00 https://pharmadispatch.com/news/yervoy-success-highlights-managed-entry-challenge 2018-02-20T16:00:01+11:00 https://pharmadispatch.com/news/mount-kosciuszko-challenge-on-way-to-fundraising-record 2018-02-20T16:00:01+11:00 https://pharmadispatch.com/news/this-is-a-reform-negotiation 2018-02-21T16:00:01+11:00 https://pharmadispatch.com/news/department-admits-it-did-not-consult-industry-on-new-model 2018-02-21T16:00:01+11:00 https://pharmadispatch.com/news/industry-recognised-by-gender-quality-agency 2018-02-21T16:00:01+11:00 https://pharmadispatch.com/news/did-the-department-break-its-own-rules 2018-02-21T16:00:01+11:00 https://pharmadispatch.com/news/ex-az-exec-building-local-company 2018-02-21T16:00:01+11:00 https://pharmadispatch.com/news/jane-orr 2018-02-22T16:00:01+11:00 https://pharmadispatch.com/news/gbma-confirms-new-ceo-on-major-day-for-industry 2018-02-22T16:00:01+11:00 https://pharmadispatch.com/news/further-evidence-of-hcv-drop-in-ebos-result 2018-02-22T16:00:01+11:00 https://pharmadispatch.com/news/ma-appoints-ex-senior-official-to-key-role 2018-02-23T16:00:01+11:00 https://pharmadispatch.com/news/positive-results-for-biogens-spinraza-in-later-onset-patients 2018-02-23T16:00:01+11:00 https://pharmadispatch.com/news/amgen-sents-pegfilgrastim-to-juno 2018-02-23T16:00:01+11:00 https://pharmadispatch.com/news/another-deal-for-australian-biotech-company 2018-02-23T16:00:01+11:00 https://pharmadispatch.com/news/canberra-is-a-very-small-place 2018-02-26T15:00:01+11:00 https://pharmadispatch.com/news/abbvie-backs-new-parkinsons-campaign 2018-02-26T15:00:01+11:00 https://pharmadispatch.com/news/roundtable-works-on-spinraza-access 2018-02-26T15:00:01+11:00 https://pharmadispatch.com/news/prep-for-pbs-as-early-asapril 2018-02-26T15:00:01+11:00 https://pharmadispatch.com/news/a-good-time-for-senate-estimates 2018-02-26T15:00:01+11:00 https://pharmadispatch.com/news/government-pushing-on-with-rebate-change-but-implementation-the- 2018-02-27T16:00:01+11:00 https://pharmadispatch.com/news/286bn-in-new-listings-really 2018-02-27T16:00:01+11:00 https://pharmadispatch.com/news/more-teams-join-pharma2peak-cup-competition 2018-02-27T16:00:01+11:00 https://pharmadispatch.com/news/king-review-final-report-complicated 2018-02-27T16:00:01+11:00 https://pharmadispatch.com/news/new-study-backs-catheter-ablation 2018-02-27T17:01:01+11:00 https://pharmadispatch.com/news/data-demand-a-key-cause-of-dissent 2018-02-28T16:00:01+11:00 https://pharmadispatch.com/news/has-industry-ever-had-this-power 2018-02-28T16:00:01+11:00 https://pharmadispatch.com/news/biogen-backs-new-educational-project 2018-02-28T16:00:01+11:00 https://pharmadispatch.com/news/fda-grants-orphan-designation-to-kazias-gdc-0084 2018-02-28T16:00:01+11:00 https://pharmadispatch.com/news/department-of-health-creates-new-pbs-taskforce 2018-03-01T16:00:01+11:00 https://pharmadispatch.com/news/az-helped-bennelong-mp-with-close-shave 2018-03-01T16:00:01+11:00 https://pharmadispatch.com/news/us-company-chooses-australia-for-trials 2018-03-01T16:00:01+11:00 https://pharmadispatch.com/news/officials-confirm-pbs-fall-again 2018-03-01T16:00:01+11:00 https://pharmadispatch.com/news/rebates-around-23-billion-in-2017-18 2018-03-02T16:00:01+11:00 https://pharmadispatch.com/news/mayne-boosts-us-product-range 2018-03-02T16:00:01+11:00 https://pharmadispatch.com/news/are-they-really-new-medicines 2018-03-02T16:00:01+11:00 https://pharmadispatch.com/news/little-progress-following-latest-meeting-on-rebate-reform 2018-03-05T15:00:01+11:00 https://pharmadispatch.com/news/ignore-any-claytons-promise-of-new-money 2018-03-05T15:00:01+11:00 https://pharmadispatch.com/news/carlo-montagner-are-entrepreneurs-born-or-made 2018-03-05T15:00:01+11:00 https://pharmadispatch.com/news/carlo-montagner-are-entrepreneurs-born-or-made-1 2018-03-06T16:00:01+11:00 https://pharmadispatch.com/news/uptake-drivers-apply-to-all-biosimilars 2018-03-05T15:00:01+11:00 https://pharmadispatch.com/news/current-therapies-remain-a-problem-for-new-breast-cancer-treatme 2018-03-05T15:00:01+11:00 https://pharmadispatch.com/news/msd-cooking-up-a-mt-kosi-storm 2018-03-06T16:00:01+11:00 https://pharmadispatch.com/news/is-a-no-growth-pbs-sustainable 2018-03-06T16:00:01+11:00 https://pharmadispatch.com/news/industry-constructive-on-reform-but-not-happy 2018-03-06T16:00:01+11:00 https://pharmadispatch.com/news/azs-liz-chatwin-time-to-be-more-strategic1 2018-03-07T16:00:01+11:00 https://pharmadispatch.com/news/researcher-highlights-bridge-program-opportunity 2018-03-07T16:00:01+11:00 https://pharmadispatch.com/news/ma-urges-caution-on-any-opioid-change 2018-03-07T16:00:01+11:00 https://pharmadispatch.com/news/wholesalers-facing-another-review 2018-03-07T16:00:01+11:00 https://pharmadispatch.com/news/going-direct-a-symptom-of-reform-impact 2018-03-08T16:00:01+11:00 https://pharmadispatch.com/news/recent-workshop-advances-process-review 2018-03-08T16:00:01+11:00 https://pharmadispatch.com/news/ma-recognises-award-winners 2018-03-08T16:00:01+11:00 https://pharmadispatch.com/news/victorian-aiming-for-more-clinical-trials 2018-03-08T16:00:01+11:00 https://pharmadispatch.com/news/special-price-agreements-even-more-complex-than-many-think 2018-03-09T16:00:01+11:00 https://pharmadispatch.com/news/australia-not-alone-on-rebates-and-no-growth 2018-03-09T16:00:01+11:00 https://pharmadispatch.com/news/guild-disappointed-with-employer-group 2018-03-09T16:00:01+11:00 https://pharmadispatch.com/news/sydney-based-regeneus-confirms-positive-data 2018-03-09T16:00:01+11:00 https://pharmadispatch.com/news/massive-cost-of-rebate-change 2018-03-12T16:00:01+11:00 https://pharmadispatch.com/news/can-the-sector-really-trust-this-change 2018-03-12T16:00:01+11:00 https://pharmadispatch.com/news/msd-and-eisai-enter-us58bn-cancer-deal 2018-03-12T16:00:01+11:00 https://pharmadispatch.com/news/new-report-confirms-patchy-uptake-of-hcv-therapies 2018-03-12T16:00:01+11:00 https://pharmadispatch.com/news/gp-prescribing-the-gap-as-treatment-numbers-stagnate 2018-03-13T16:00:01+11:00 https://pharmadispatch.com/news/goal-in-sight-as-trekkers-prepare-for-mt-kosi-challenge 2018-03-13T16:00:01+11:00 https://pharmadispatch.com/news/no-secret-over-what-medicines-have-special-pricing-arrangements 2018-03-13T16:00:01+11:00 https://pharmadispatch.com/news/noxopharm-reports-cep-1-study-results 2018-03-13T16:00:01+11:00 https://pharmadispatch.com/news/ma-searching-for-new-ceo 2018-03-13T22:39:01+11:00 https://pharmadispatch.com/news/divide-and-conquer-is-the-strategy 2018-03-14T16:00:01+11:00 https://pharmadispatch.com/news/australia-boosting-bayer-in-the-region 2018-03-14T16:00:01+11:00 https://pharmadispatch.com/news/besins-advises-on-supply-concerns 2018-03-14T16:00:01+11:00 https://pharmadispatch.com/news/us-investors-pursue-immuron 2018-03-14T16:00:01+11:00 https://pharmadispatch.com/news/taking-the-very-simple-and-making-it-complicated 2018-03-15T16:00:01+11:00 https://pharmadispatch.com/news/the-societal-agreement-must-be-retained 2018-03-15T16:00:01+11:00 https://pharmadispatch.com/news/study-confirms-benefit-of-il-17a-inhibitor 2018-03-15T16:00:01+11:00 https://pharmadispatch.com/news/government-working-to-reach-agreement-on-grant 2018-03-15T16:00:01+11:00 https://pharmadispatch.com/news/new-website-highlights-global-biotech-industry 2018-03-16T16:00:01+11:00 https://pharmadispatch.com/news/rebates-dominate-managing-director-meetings 2018-03-16T16:00:01+11:00 https://pharmadispatch.com/news/company-total-tops-65000-as-mt-kosi-records-tumble 2018-03-16T16:00:01+11:00 https://pharmadispatch.com/news/could-be-rebates-for-new-ebos-cfo 2018-03-16T16:00:01+11:00 https://pharmadispatch.com/news/patients-families-and-friends-lead-the-way-as-every-record-broke 2018-03-19T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-calls-sector-wide-meeting-on-rebate-reform 2018-03-19T16:00:01+11:00 https://pharmadispatch.com/news/latest-dusc-utilisation-review 2018-03-19T16:00:01+11:00 https://pharmadispatch.com/news/immutep-attracts-new-investment 2018-03-19T16:00:01+11:00 https://pharmadispatch.com/news/section-seven-providing-the-best-defence 2018-03-19T16:00:01+11:00 https://pharmadispatch.com/news/is-this-stability-and-certainty 2018-03-20T16:00:01+11:00 https://pharmadispatch.com/news/meetings-in-advance-of-sector-discussion 2018-03-20T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-confirms-april-prep-listing 2018-03-21T16:00:01+11:00 https://pharmadispatch.com/news/a-new-immunotherapy-for-april-pbs 2018-03-20T16:00:01+11:00 https://pharmadispatch.com/news/political-battle-over-stem-visas 2018-03-20T16:00:01+11:00 https://pharmadispatch.com/news/oral-contraceptive-as-a-discretionary-medicine 2018-03-21T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-rebate-reform-will-happen 2018-03-21T16:00:01+11:00 https://pharmadispatch.com/news/tga-confirms-provisional-approval-criteria 2018-03-21T16:00:01+11:00 https://pharmadispatch.com/news/too-hard-to-assess-clinical-outcomes-from-pbs-medicines 2018-03-22T16:00:01+11:00 https://pharmadispatch.com/news/gbma-on-the-lookout-for-grant-manager 2018-03-22T16:00:01+11:00 https://pharmadispatch.com/news/ma-hoping-for-mid-year-appointment 2018-03-22T16:00:01+11:00 https://pharmadispatch.com/news/dentons-acquires-leading-life-sciences-law-firm 2018-03-22T16:00:01+11:00 https://pharmadispatch.com/news/rb-drops-out-of-race-for-pfizer-consumer-health-business 2018-03-23T16:00:01+11:00 https://pharmadispatch.com/news/industry-suggests-a-review-of-old-pricing-arrangements 2018-03-22T21:49:01+11:00 https://pharmadispatch.com/news/positive-early-signs-for-new-uptake-drivers 2018-03-23T16:00:01+11:00 https://pharmadispatch.com/news/april-brings-more-good-news-for-mundipharma 2018-03-23T16:00:01+11:00 https://pharmadispatch.com/news/new-rebate-system-could-rely-on-stickers 2018-03-26T16:00:01+11:00 https://pharmadispatch.com/news/australia-must-make-the-case-for-investment 2018-03-26T16:00:01+11:00 https://pharmadispatch.com/news/april-brings-major-change-for-diabetes-medicines 2018-03-26T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-confirms-new-listings 2018-03-26T16:00:01+11:00 https://pharmadispatch.com/news/gsk-says-withdraws-from-pfizer-consumer-health-sale 2018-03-26T16:00:01+11:00 https://pharmadispatch.com/news/now-is-the-time-to-say-no 2018-03-27T16:00:01+11:00 https://pharmadispatch.com/news/az-backing-local-school-initiative 2018-03-27T16:00:01+11:00 https://pharmadispatch.com/news/abbvies-kirsten-odoherty-pay-gap-remains-a-major-problem 2018-03-27T16:00:01+11:00 https://pharmadispatch.com/news/guild-more-urgency-required-on-flu-vax 2018-03-27T16:00:01+11:00 https://pharmadispatch.com/news/concern-grows-as-hcv-initiations-fall-again 2018-03-28T16:00:01+11:00 https://pharmadispatch.com/news/policy-head-appointed-interim-ceo 2018-03-28T16:00:01+11:00 https://pharmadispatch.com/news/tga-strikes-balance-on-shortages 2018-03-28T16:00:01+11:00 https://pharmadispatch.com/news/gsk-buys-novartis-joint-venture-stake 2018-03-28T16:00:01+11:00 https://pharmadispatch.com/news/gilead-secures-another-hcv-approval 2018-03-28T16:00:01+11:00 https://pharmadispatch.com/news/why-is-the-government-ignoring-more-workable-alternatives 2018-03-29T16:00:01+11:00 https://pharmadispatch.com/news/strategy-review-needed-if-treatment-decline-confirmed 2018-03-29T16:00:01+11:00 https://pharmadispatch.com/news/focus-on-patients-member-companies-and-pbs-future 2018-03-29T16:00:01+11:00 https://pharmadispatch.com/news/parliamentary-tribute-to-the-late-donna-staunton 2018-03-29T16:00:01+11:00 https://pharmadispatch.com/news/psa-announces-new-ceo 2018-03-29T16:00:01+11:00 https://pharmadispatch.com/news/industry-still-pushing-for-cost-recovery-delay 2018-04-03T15:00:01+10:00 https://pharmadispatch.com/news/could-accc-help-on-rebate-reform 2018-04-03T15:00:01+10:00 https://pharmadispatch.com/news/takeda-in-potential-bid-for-shire 2018-04-03T15:00:01+10:00 https://pharmadispatch.com/news/martin-palin-humanising-big-companies 2018-04-03T15:00:01+10:00 https://pharmadispatch.com/news/more-companies-confirming-magnitude-of-us-rebates 2018-04-05T15:00:01+10:00 https://pharmadispatch.com/news/wider-access-for-allergans-ozurdex 2018-04-04T15:00:01+10:00 https://pharmadispatch.com/news/pbac-concerned-if-hcv-decline-continues 2018-04-04T15:00:01+10:00 https://pharmadispatch.com/news/clinicians-welcome-tremfya-registration 2018-04-04T04:31:01+10:00 https://pharmadispatch.com/news/rare-cancers-marks-mt-kosi-success 2018-04-04T15:00:01+10:00 https://pharmadispatch.com/news/pg-in-talks-over-pfizer-consumer-health-business 2018-04-04T15:46:01+10:00 https://pharmadispatch.com/news/process-review-looking-at-submission-categories 2018-04-05T15:00:01+10:00 https://pharmadispatch.com/news/ma-advisory-council-to-consider-value-of-medicines-project 2018-04-05T15:00:01+10:00 https://pharmadispatch.com/news/drug-costs-a-concern 2018-04-05T15:00:01+10:00 https://pharmadispatch.com/news/what-happens-if-a-competitor-agrees-to-rebate-change 2018-04-06T15:00:01+10:00 https://pharmadispatch.com/news/bayer-backs-emerging-cv-researchers 2018-04-06T15:00:01+10:00 https://pharmadispatch.com/news/time-key-in-value-project 2018-04-06T15:00:01+10:00 https://pharmadispatch.com/news/industry-caught-in-emerging-trade-war 2018-04-06T15:00:01+10:00 https://pharmadispatch.com/news/department-recalls-pbs-update 2018-04-09T15:00:01+10:00 https://pharmadispatch.com/news/industry-reputation-on-the-up-in-latest-patient-survey 2018-04-08T20:33:01+10:00 https://pharmadispatch.com/news/hcv-uptake-settling-at-low-levels 2018-04-09T15:00:01+10:00 https://pharmadispatch.com/news/biotron-updates-on-new-hiv-therapy 2018-04-09T15:00:01+10:00 https://pharmadispatch.com/news/industry-calls-for-rd-tax-carve-out 2018-04-10T15:00:01+10:00 https://pharmadispatch.com/news/bridge-program-welcomes-98-new-participants 2018-04-10T15:00:01+10:00 https://pharmadispatch.com/news/novartis-acquires-gene-therapy-company-for-us87bn 2018-04-10T15:00:01+10:00 https://pharmadispatch.com/news/company-anger-over-recall-of-schedule-update 2018-04-10T15:00:01+10:00 https://pharmadispatch.com/news/running-for-rare-in-boston 2018-04-11T15:00:01+10:00 https://pharmadispatch.com/news/experts-welcome-expanded-indication-for-serviers-latuda 2018-04-11T15:00:01+10:00 https://pharmadispatch.com/news/belinda-wood-psa-role-an-easy-decision 2018-04-11T15:00:01+10:00 https://pharmadispatch.com/news/btf-fund-manager-invests-in-melbourne-based-company 2018-04-11T02:21:01+10:00 https://pharmadispatch.com/news/new-chair-for-gbma 2018-04-13T15:00:01+10:00 https://pharmadispatch.com/news/ma-plans-go-ahead-on-consumer-sentiment-index 2018-04-12T15:00:01+10:00 https://pharmadispatch.com/news/value-based-healthcare-inevitable 2018-04-12T15:00:01+10:00 https://pharmadispatch.com/news/the-new-pbs-is-about-contracts-not-hta 2018-04-12T15:00:01+10:00 https://pharmadispatch.com/news/bionomics-progresses-ptsd-trial 2018-04-12T15:00:01+10:00 https://pharmadispatch.com/news/more-flexible-application-of-special-pricing-arrangements 2018-04-13T15:00:01+10:00 https://pharmadispatch.com/news/uptake-drivers-hit-a-hospital-roadblock 2018-04-16T15:00:01+10:00 https://pharmadispatch.com/news/international-recognition-for-australian-patient-initiative 2018-04-13T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-launches-new-menb-vaccine 2018-04-13T15:00:01+10:00 https://pharmadispatch.com/news/lundbeck-confirms-settlement-with-alphapharm 2018-04-13T15:00:01+10:00 https://pharmadispatch.com/news/confusion-and-opportunity-on-special-pricing-arrangements 2018-04-16T15:00:01+10:00 https://pharmadispatch.com/news/are-current-delays-just-deferrals-in-disguise 2018-04-16T15:00:01+10:00 https://pharmadispatch.com/news/merck-employees-celebrate-350th-anniversary 2018-04-16T15:00:01+10:00 https://pharmadispatch.com/news/amgen-joins-digital-health-crc 2018-04-16T15:00:01+10:00 https://pharmadispatch.com/news/minister-announces-new-listings 2018-04-16T15:00:01+10:00 https://pharmadispatch.com/news/no-flexibility-on-special-pricing-arrangements-unless 2018-04-17T15:00:01+10:00 https://pharmadispatch.com/news/csl-behring-commits-on-world-haemophilia-day 2018-04-17T15:00:01+10:00 https://pharmadispatch.com/news/digital-health-start-up-looking-to-promote-adherence 2018-04-17T15:00:01+10:00 https://pharmadispatch.com/news/servier-acquires-shire-oncology-business 2018-04-17T15:00:01+10:00 https://pharmadispatch.com/news/once-contentious-is-now-confusing 2018-04-18T15:00:01+10:00 https://pharmadispatch.com/news/sanofi-sells-european-generics-business 2018-04-18T15:00:01+10:00 https://pharmadispatch.com/news/seqirus-announces-png-antivenom-initiative 2018-04-18T15:00:01+10:00 https://pharmadispatch.com/news/bms-and-janssen-team-up-on-new-anticoagulant 2018-04-18T15:00:01+10:00 https://pharmadispatch.com/news/pbs-listing-process-descends-into-farce 2018-04-19T15:00:01+10:00 https://pharmadispatch.com/news/a-serious-industry-deserving-of-serious-decisions 2018-04-19T15:00:01+10:00 https://pharmadispatch.com/news/mayne-officially-opens-us-facility 2018-04-20T15:00:01+10:00 https://pharmadispatch.com/news/the-question-is-why-now 2018-04-20T15:00:01+10:00 https://pharmadispatch.com/news/new-report-show-rebates-average-44-in-new-zealand 2018-04-20T15:00:01+10:00 https://pharmadispatch.com/news/merck-sells-consumer-health-business 2018-04-20T15:00:01+10:00 https://pharmadispatch.com/news/shire-rejects-third-bid-from-takeda 2018-04-20T15:00:01+10:00 https://pharmadispatch.com/news/abbvie-not-yet-on-venclexta-but-future-is-positive 2018-04-23T15:00:01+10:00 https://pharmadispatch.com/news/a-proud-industry-committed-to-doing-the-right-thing 2018-04-23T15:00:01+10:00 https://pharmadispatch.com/news/march-pbac-outcomes-1 2018-04-23T15:00:01+10:00 https://pharmadispatch.com/news/gbma-confirms-biosimilar-education-grant 2018-04-23T15:00:01+10:00 https://pharmadispatch.com/news/new-deal-raises-questions-over-the-need-for-rebate-pilot 2018-04-24T15:00:01+10:00 https://pharmadispatch.com/news/guild-extend-access-to-flu-vaccine 2018-04-24T15:00:01+10:00 https://pharmadispatch.com/news/new-research-on-triple-therapy-in-advance-of-pbs-listing 2018-04-24T15:00:01+10:00 https://pharmadispatch.com/news/patients-to-access-cancer-treatment-at-home 2018-04-24T15:00:01+10:00 https://pharmadispatch.com/news/march-quarter-drug-prices-remain-low 2018-04-26T15:00:01+10:00 https://pharmadispatch.com/news/discretion-price-cut-anniversary 2018-04-27T15:00:01+10:00 https://pharmadispatch.com/news/not-so-important-after-all 2018-04-26T15:00:01+10:00 https://pharmadispatch.com/news/wider-implications-of-pivotal-legal-advice 2018-04-26T15:00:01+10:00 https://pharmadispatch.com/news/shire-accepts-us64bn-proposal-from-takeda 2018-04-26T15:00:01+10:00 https://pharmadispatch.com/news/the-facts-remain-unchallenged 2018-04-27T15:00:01+10:00 https://pharmadispatch.com/news/new-resource-targeting-hbv-stigma 2018-04-27T15:00:01+10:00 https://pharmadispatch.com/news/another-indication-for-opdivo 2018-04-27T15:00:01+10:00 https://pharmadispatch.com/news/biosimilars-headline-july-pbac 2018-04-30T15:00:01+10:00 https://pharmadispatch.com/news/there-must-have-been-a-formal-review 2018-04-30T15:00:01+10:00 https://pharmadispatch.com/news/supply-chain-pilot-delayed-until-after-election 2018-04-30T15:00:01+10:00 https://pharmadispatch.com/news/lauren-carey-equitable-outcomes-means-equitable-access 2018-04-30T15:00:01+10:00 https://pharmadispatch.com/news/msd-australia-unlikely-to-meet-hcv-target-without-action 2018-05-01T15:00:01+10:00 https://pharmadispatch.com/news/mundipharma-launches-new-treatment-for-common-cold 2018-05-01T15:00:01+10:00 https://pharmadispatch.com/news/new-research-ms-under-the-radar 2018-05-01T15:00:01+10:00 https://pharmadispatch.com/news/medtech-version-of-the-bridge-program 2018-05-01T15:00:01+10:00 https://pharmadispatch.com/news/a-significant-and-precedent-setting-statement 2018-05-02T15:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-announces-new-ceo 2018-05-02T15:00:01+10:00 https://pharmadispatch.com/news/ama-backs-shortage-model-but-wants-more-responsive-pbs 2018-05-02T15:00:01+10:00 https://pharmadispatch.com/news/uwa-and-douglas-partner-on-immunotherapies 2018-05-02T15:00:01+10:00 https://pharmadispatch.com/news/it-is-recycling-not-new-spending 2018-05-03T15:00:01+10:00 https://pharmadispatch.com/news/final-speaker-confirmed-for-pharmadispatch-conference 2018-05-03T15:00:01+10:00 https://pharmadispatch.com/news/long-awaited-final-report-expected-today 2018-05-03T15:00:01+10:00 https://pharmadispatch.com/news/major-change-in-department-of-health-leadership 2018-05-03T15:00:01+10:00 https://pharmadispatch.com/news/the-end-of-an-awkward-marriage 2018-05-04T15:00:01+10:00 https://pharmadispatch.com/news/industry-welcomes-commitment-but-remains-very-cautious 2018-05-04T15:00:01+10:00 https://pharmadispatch.com/news/az-welcomes-fasenra-approval 2018-05-04T15:00:01+10:00 https://pharmadispatch.com/news/starpharma-signs-major-deal-with-mundipharma 2018-05-04T15:00:01+10:00 https://pharmadispatch.com/news/labor-alarmed-over-pbac-advice 2018-05-04T20:15:01+10:00 https://pharmadispatch.com/news/government-acts-quickly-to-list-biogens-spinraza 2018-05-07T15:00:01+10:00 https://pharmadispatch.com/news/the-problem-with-exceptions 2018-05-07T15:00:01+10:00 https://pharmadispatch.com/news/chinese-company-enters-race-for-sirtex 2018-05-07T15:00:01+10:00 https://pharmadispatch.com/news/us-move-to-classify-rebates-as-kickbacks 2018-05-07T15:00:01+10:00 https://pharmadispatch.com/news/bayers-nelson-ambrogio-a-purpose-driven-culture 2018-05-07T15:00:01+10:00 https://pharmadispatch.com/news/health-minister-greg-hunt-has-announced-the-government-will-fund 2018-05-07T15:00:01+10:00 https://pharmadispatch.com/news/consistently-inconsistent-on-pbs-interventions 2018-05-08T15:00:01+10:00 https://pharmadispatch.com/news/missed-opportunity-is-the-risk-for-australia 2018-05-08T15:00:01+10:00 https://pharmadispatch.com/news/seniors-not-prioritising-shingles-vax 2018-05-08T15:00:01+10:00 https://pharmadispatch.com/news/sector-welcomes-new-mtpconnect-ceo 2018-05-08T15:00:01+10:00 https://pharmadispatch.com/news/industry-this-is-your-reward 2018-05-09T15:00:01+10:00 https://pharmadispatch.com/news/budget-2018-19-the-measures 2018-05-09T15:00:01+10:00 https://pharmadispatch.com/news/contingency-reserve-gone 2018-05-09T15:00:01+10:00 https://pharmadispatch.com/news/budget-2018-19-the-response 2018-05-09T08:24:01+10:00 https://pharmadispatch.com/news/why-is-the-pbs-being-starved-of-funding 2018-05-10T15:00:01+10:00 https://pharmadispatch.com/news/merger-to-create-generic-giant 2018-05-10T15:00:01+10:00 https://pharmadispatch.com/news/mpa-pbs-needs-further-investment 2018-05-10T15:00:01+10:00 https://pharmadispatch.com/news/failure-to-act-unconscionable 2018-05-10T15:00:01+10:00 https://pharmadispatch.com/news/ex-adviser-joins-industry 2018-05-11T15:00:01+10:00 https://pharmadispatch.com/news/a-starvation-diet-over-ten-years 2018-05-11T04:55:01+10:00 https://pharmadispatch.com/news/why-the-second-statement 2018-05-11T15:00:01+10:00 https://pharmadispatch.com/news/minister-calls-meeting-as-budget-response-falls-flat 2018-05-14T15:00:01+10:00 https://pharmadispatch.com/news/sector-gathers-for-pharmadispatch-conference 2018-05-14T15:00:01+10:00 https://pharmadispatch.com/news/department-starts-cso-review 2018-05-14T15:00:01+10:00 https://pharmadispatch.com/news/trump-time-to-end-the-global-freeloading 2018-05-14T15:00:01+10:00 https://pharmadispatch.com/news/flood-of-requests-for-ministerial-discretion 2018-05-15T15:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-conference-wrap-up 2018-05-15T15:00:01+10:00 https://pharmadispatch.com/news/my-health-record-opt-out-period-confirmed 2018-05-15T15:00:01+10:00 https://pharmadispatch.com/news/labor-setting-its-own-course-on-pbs 2018-05-15T18:42:01+10:00 https://pharmadispatch.com/news/the-mystery-of-bp1-statement-6 2018-05-16T00:57:01+10:00 https://pharmadispatch.com/news/pharmadispatch-conference-the-jane-halton-masterclass 2018-05-16T15:00:01+10:00 https://pharmadispatch.com/news/industry-is-not-a-cheerleader 2018-05-16T15:00:01+10:00 https://pharmadispatch.com/news/discretion-to-say-no 2018-05-16T15:00:01+10:00 https://pharmadispatch.com/news/busy-week-sets-tone-to-2020 2018-05-17T15:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-conference-video-recap 2018-05-17T15:00:01+10:00 https://pharmadispatch.com/news/big-day-for-clinical-trials 2018-05-17T15:00:01+10:00 https://pharmadispatch.com/news/minister-meets-industry-on-budget-response 2018-05-17T15:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-conference-video-recap-2 2018-05-18T15:00:01+10:00 https://pharmadispatch.com/news/compare-and-contrast-the-funding 2018-05-18T15:00:01+10:00 https://pharmadispatch.com/news/savings-are-now-re-prioritisations 2018-05-18T15:00:01+10:00 https://pharmadispatch.com/news/patrys-adds-new-research-collaboration 2018-05-18T15:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2018-video-recap-3-the-national-medicines-policy 2018-05-21T15:00:01+10:00 https://pharmadispatch.com/news/new-savings-are-inevitable 2018-05-21T15:00:01+10:00 https://pharmadispatch.com/news/investors-cheer-csl-upgrade 2018-05-21T15:00:01+10:00 https://pharmadispatch.com/news/comeback-for-another-medicines-working-group 2018-05-21T15:00:01+10:00 https://pharmadispatch.com/news/nominations-open-for-annual-gsk-research-award 2018-05-22T15:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2018-video-recap-4-predictability-and-certainty 2018-05-22T15:00:01+10:00 https://pharmadispatch.com/news/june-listings-include-key-generics 2018-05-22T15:00:01+10:00 https://pharmadispatch.com/news/call-for-submissions-to-pan-tumour-review 2018-05-22T15:00:01+10:00 https://pharmadispatch.com/news/asmi-urges-backing-for-legislation 2018-05-23T14:00:01+10:00 https://pharmadispatch.com/news/recognition-for-swisse-for-china-growth 2018-05-23T14:00:01+10:00 https://pharmadispatch.com/news/its-a-long-game-and-we-have-to-build-stakeholder-support-says-ma 2018-05-23T14:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2018-video-recap-5-budget-2018-19 2018-05-23T14:00:01+10:00 https://pharmadispatch.com/news/careful-language-as-hcv-elimination-goal-slips 2018-05-24T15:00:01+10:00 https://pharmadispatch.com/news/government-delays-new-cost-recovery-model 2018-05-24T15:00:01+10:00 https://pharmadispatch.com/news/positive-news-for-australian-company-actinogen 2018-05-24T15:00:01+10:00 https://pharmadispatch.com/news/us-company-decides-not-to-match-sirtex-bid 2018-05-24T15:00:01+10:00 https://pharmadispatch.com/news/bms-updates-study-connect-website 2018-05-24T15:00:01+10:00 https://pharmadispatch.com/news/us-congress-backs-right-to-try-law 2018-05-24T15:00:01+10:00 https://pharmadispatch.com/news/emerging-prota-completes-enrolment-of-new-trial 2018-05-25T15:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-spike-in-hospital-chemo 2018-05-25T15:00:01+10:00 https://pharmadispatch.com/news/australians-want-control-over-health-data-1 2018-05-25T15:00:01+10:00 https://pharmadispatch.com/news/timing-a-problem-for-supply-chain-changes 2018-05-29T15:00:01+10:00 https://pharmadispatch.com/news/hunt-extra-vaccines-already-on-the-way 2018-05-28T15:00:01+10:00 https://pharmadispatch.com/news/time-to-brace-for-a-surprise 2018-05-28T15:00:01+10:00 https://pharmadispatch.com/news/victory-for-pfizer-over-accc 2018-05-28T15:00:01+10:00 https://pharmadispatch.com/news/new-leadership-for-merck-australia-nz 2018-05-28T15:00:01+10:00 https://pharmadispatch.com/news/over-600-attend-biomelbourne-network-connecting-women-lunch 2018-05-28T15:00:01+10:00 https://pharmadispatch.com/news/stakeholders-welcome-1-june-listings 2018-05-27T15:00:01+10:00 https://pharmadispatch.com/news/the-need-for-balance-as-election-approaches 2018-05-29T15:00:01+10:00 https://pharmadispatch.com/news/us-company-goes-to-court-over-bid-for-sirtex 2018-05-29T15:00:01+10:00 https://pharmadispatch.com/news/seqirus-announces-practice-nurse-grants 2018-05-29T15:00:01+10:00 https://pharmadispatch.com/news/and-here-is-the-surprise 2018-05-29T15:00:01+10:00 https://pharmadispatch.com/news/rebate-change-artificially-dropping-pbs-spend 2018-05-30T15:00:01+10:00 https://pharmadispatch.com/news/agreement-done-before-rebate-change-considered 2018-05-30T15:00:01+10:00 https://pharmadispatch.com/news/confirmed-leadership-for-gsk-consumer-health 2018-05-30T15:00:01+10:00 https://pharmadispatch.com/news/more-pbs-damages-cases-likely 2018-05-30T15:00:01+10:00 https://pharmadispatch.com/news/research-the-theme-for-world-ms-day 2018-05-30T15:00:01+10:00 https://pharmadispatch.com/news/update-from-senate-estimates 2018-05-30T20:48:01+10:00 https://pharmadispatch.com/news/criteria-what-criteria 2018-05-31T15:00:01+10:00 https://pharmadispatch.com/news/us-global-asset-manager-increases-stake-in-cynata 2018-05-31T15:00:01+10:00 https://pharmadispatch.com/news/ma-approached-department-on-spas 2018-05-31T15:00:01+10:00 https://pharmadispatch.com/news/ato-highlights-focus-on-industry 2018-05-31T15:00:01+10:00 https://pharmadispatch.com/news/labor-asks-for-anao-investigation 2018-05-31T20:03:01+10:00 https://pharmadispatch.com/news/implications-of-anao-review 2018-06-01T15:00:01+10:00 https://pharmadispatch.com/news/another-acquisition-for-australian-first-pharma 2018-06-01T15:00:01+10:00 https://pharmadispatch.com/news/csl-seeking-2019-fellowship-applicants 2018-06-01T15:00:01+10:00 https://pharmadispatch.com/news/politics-is-a-tough-business-but 2018-06-04T15:00:01+10:00 https://pharmadispatch.com/news/sanofi-welcomes-more-flu-vaccine 2018-06-01T15:00:01+10:00 https://pharmadispatch.com/news/bi-statement-on-giotrif 2018-06-01T15:00:01+10:00 https://pharmadispatch.com/news/dhls-resnick-manufacturers-should-stand-their-ground 2018-06-04T15:00:01+10:00 https://pharmadispatch.com/news/pharmaceutical-industry-in-the-tax-spotlight 2018-06-03T15:00:01+10:00 https://pharmadispatch.com/news/pbac-boost-for-filgrastim-biosimilars 2018-06-04T15:00:01+10:00 https://pharmadispatch.com/news/does-the-review-normally-come-first 2018-06-03T15:00:01+10:00 https://pharmadispatch.com/news/overall-survival-win-for-keytruda 2018-06-05T15:00:01+10:00 https://pharmadispatch.com/news/product-failure-laid-the-groundwork-for-success 2018-06-05T15:00:01+10:00 https://pharmadispatch.com/news/older-drugs-the-only-winners-on-discretions 2018-06-05T15:00:01+10:00 https://pharmadispatch.com/news/1landmark-study-shows-chemo-not-needed-for-most-early-breast-can 2018-06-05T15:00:01+10:00 https://pharmadispatch.com/news/four-cases-with-more-to-come 2018-06-07T14:00:01+10:00 https://pharmadispatch.com/news/funding-unlikely-for-breast-cancer-test 2018-06-06T14:00:01+10:00 https://pharmadispatch.com/news/department-breaches-dozens-of-pbs-contracts 2018-06-06T15:00:01+10:00 https://pharmadispatch.com/news/confidential-documents-must-be-returned 2018-06-06T14:00:01+10:00 https://pharmadispatch.com/news/shire-backs-new-australian-company 2018-06-06T14:00:01+10:00 https://pharmadispatch.com/news/the-confidential-information-has-been-published 2018-06-07T15:00:01+10:00 https://pharmadispatch.com/news/this-is-also-highly-unusual 2018-06-07T01:13:01+10:00 https://pharmadispatch.com/news/senate-inquiry-ban-pharma-donations 2018-06-07T15:00:01+10:00 https://pharmadispatch.com/news/this-is-why-companies-should-have-been-consulted 2018-06-07T15:00:01+10:00 https://pharmadispatch.com/news/department-halts-further-publication-of-pricing-poster 2018-06-07T15:05:01+10:00 https://pharmadispatch.com/news/response-pathetic-as-clock-ticks-on-undertakings 2018-06-12T14:00:01+10:00 https://pharmadispatch.com/news/companies-demand-destruction-of-poster 2018-06-08T15:00:01+10:00 https://pharmadispatch.com/news/it-would-not-have-been-a-straightforward-process 2018-06-08T15:00:01+10:00 https://pharmadispatch.com/news/nhmrc-response-on-grant 2018-06-08T15:00:01+10:00 https://pharmadispatch.com/news/merck-and-pfizer-announce-more-bavencio-data 2018-06-08T15:00:01+10:00 https://pharmadispatch.com/news/questions-over-initial-response-and-timeline 2018-06-12T14:00:01+10:00 https://pharmadispatch.com/news/recognition-for-ex-msd-executive 2018-06-12T14:00:01+10:00 https://pharmadispatch.com/news/england-confirms-routine-funding-for-keytruda-in-lung-cancer 2018-06-12T14:00:01+10:00 https://pharmadispatch.com/news/ma-confirms-new-ceo 2018-06-12T21:00:01+10:00 https://pharmadispatch.com/news/nhmrc-not-informed-of-any-significant-variations 2018-06-13T15:00:01+10:00 https://pharmadispatch.com/news/recognition-for-gilead-head-of-rd 2018-06-13T15:00:01+10:00 https://pharmadispatch.com/news/npsa-call-for-urgent-action-to-stamp-out-monopolies 2018-06-13T15:00:01+10:00 https://pharmadispatch.com/news/amgen-welcomes-prolia-in-nz 2018-06-13T15:00:01+10:00 https://pharmadispatch.com/news/department-starts-responding-to-company-demands 2018-06-14T15:00:01+10:00 https://pharmadispatch.com/news/what-changed-to-make-it-ok-in-vancouver 2018-06-14T15:00:01+10:00 https://pharmadispatch.com/news/another-lexapro-settlement-for-lundbeck 2018-06-14T15:00:01+10:00 https://pharmadispatch.com/news/little-progress-as-discussions-restart 2018-06-14T15:00:01+10:00 https://pharmadispatch.com/news/hunt-steps-taken-to-put-a-hold-on-any-further-disclosure 2018-06-15T15:00:01+10:00 https://pharmadispatch.com/news/a-disruptive-technology-that-changed-everything 2018-06-25T15:00:01+10:00 https://pharmadispatch.com/news/issue-unlikely-to-go-away 2018-06-15T15:00:01+10:00 https://pharmadispatch.com/news/award-for-researchers-for-work-on-abbvies-venclexta 2018-06-15T15:00:01+10:00 https://pharmadispatch.com/news/janssen-scoops-regional-awards 2018-06-15T15:00:01+10:00 https://pharmadispatch.com/news/july-pbs-schedule-update 2018-06-18T15:00:01+10:00 https://pharmadispatch.com/news/new-appointment-for-gbma 2018-06-18T15:00:01+10:00 https://pharmadispatch.com/news/sirtex-accepts-19bn-takeover 2018-06-18T15:00:01+10:00 https://pharmadispatch.com/news/turnbull-government-still-turning-to-pbs 2018-06-18T15:00:01+10:00 https://pharmadispatch.com/news/one-path-might-be-better-than-the-other 2018-06-19T15:00:01+10:00 https://pharmadispatch.com/news/a-familiar-name-returns-to-lead-msd 2018-06-19T15:00:01+10:00 https://pharmadispatch.com/news/ma-spas-a-critical-element-to-ensure-access 2018-06-19T02:56:01+10:00 https://pharmadispatch.com/news/new-studies-back-sandoz-biosimilars 2018-06-19T15:00:01+10:00 https://pharmadispatch.com/news/at-least-one-company-pre-empted-discretion-process 2018-06-20T15:00:01+10:00 https://pharmadispatch.com/news/data-protection-push-likely-in-australia-eu-fta 2018-06-20T15:00:01+10:00 https://pharmadispatch.com/news/a-week-of-possibilities-becomes-a-month 2018-06-20T15:00:01+10:00 https://pharmadispatch.com/news/busy-day-for-medicines-australia 2018-06-20T15:00:01+10:00 https://pharmadispatch.com/news/hunt-only-negotiated-with-the-department 2018-06-21T15:00:01+10:00 https://pharmadispatch.com/news/debate-over-who-is-responsible-for-what 2018-06-21T15:00:01+10:00 https://pharmadispatch.com/news/stakeholders-gather-for-technical-rebate-reform-discussion 2018-06-21T15:00:01+10:00 https://pharmadispatch.com/news/what-we-do-matters 2018-06-21T15:00:01+10:00 https://pharmadispatch.com/news/new-data-on-mercks-mavenclad 2018-06-22T15:00:01+10:00 https://pharmadispatch.com/news/october-price-disclosure-reductions 2018-06-22T15:00:01+10:00 https://pharmadispatch.com/news/pbs-debate-heats-up 2018-06-22T15:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-jj-excellence-awards 2018-06-22T15:00:01+10:00 https://pharmadispatch.com/news/senate-calls-estimates-spillover-session 2018-06-25T15:00:01+10:00 https://pharmadispatch.com/news/gsk-backs-save-the-children 2018-06-25T15:00:01+10:00 https://pharmadispatch.com/news/sector-working-to-finalise-cso-review-submissions 2018-06-25T15:00:01+10:00 https://pharmadispatch.com/news/ma-brings-together-groups-for-super 2018-06-26T15:00:01+10:00 https://pharmadispatch.com/news/when-is-marketing-approval 2018-06-26T15:00:01+10:00 https://pharmadispatch.com/news/accc-trying-again-on-pfizer 2018-06-26T15:00:01+10:00 https://pharmadispatch.com/news/indigenous-australians-missing-heart-treatments 2018-06-26T15:00:01+10:00 https://pharmadispatch.com/news/data-protection-debate-far-from-over 2018-06-27T15:00:01+10:00 https://pharmadispatch.com/news/not-even-close-to-one-listing-per-day-average 2018-06-27T15:00:01+10:00 https://pharmadispatch.com/news/china-now-the-focus-in-asia 2018-06-27T15:00:01+10:00 https://pharmadispatch.com/news/consultation-on-future-mrff-priorities 2018-06-27T15:00:01+10:00 https://pharmadispatch.com/news/two-year-countdown-to-next-reform-round 2018-06-28T15:00:01+10:00 https://pharmadispatch.com/news/anao-requests-documents-on-listing 2018-06-27T19:55:01+10:00 https://pharmadispatch.com/news/40000-could-benefit-from-streamlined-process 2018-06-28T15:00:01+10:00 https://pharmadispatch.com/news/anao-silent-on-documents 2018-06-28T15:00:01+10:00 https://pharmadispatch.com/news/site-found-for-australias-largest-medicinal-cannabis-manufacturi 2018-06-28T15:00:01+10:00 https://pharmadispatch.com/news/the-context-is-what-makes-this-highly-unusual 2018-06-29T15:00:01+10:00 https://pharmadispatch.com/news/super-meeting-talks-alignment 2018-06-29T15:00:01+10:00 https://pharmadispatch.com/news/detailed-report-on-confidentiality-breach-within-days 2018-06-29T15:00:01+10:00 https://pharmadispatch.com/news/msd-a-new-process-with-funding 2018-06-29T15:00:01+10:00 https://pharmadispatch.com/news/march-adds-further-confusion-on-special-pricing-arrangements 2018-07-02T15:00:01+10:00 https://pharmadispatch.com/news/industry-picks-preferred-rebate-reform-model 2018-07-02T15:00:01+10:00 https://pharmadispatch.com/news/novartis-welcomes-kisqali-listing 2018-07-02T15:00:01+10:00 https://pharmadispatch.com/news/novartis-decides-to-spinoff-alcon 2018-07-02T15:00:01+10:00 https://pharmadispatch.com/news/one-company-punished-for-following-process 2018-07-02T15:00:01+10:00 https://pharmadispatch.com/news/guild-deregulation-an-opportunity-as-much-as-a-risk 2018-07-03T15:00:01+10:00 https://pharmadispatch.com/news/more-change-for-medicine-supply 2018-07-03T15:00:01+10:00 https://pharmadispatch.com/news/how-new-supply-chain-might-operate 2018-07-03T15:00:01+10:00 https://pharmadispatch.com/news/novo-nordisk-looking-forward-to-victoza-listing 2018-07-03T15:00:01+10:00 https://pharmadispatch.com/news/mundipharma-expands-pain-management-portfolio 2018-07-04T15:00:01+10:00 https://pharmadispatch.com/news/different-advice-led-to-different-outcomes 2018-07-04T15:05:01+10:00 https://pharmadispatch.com/news/cost-the-concern-for-small-and-mid-size-companies 2018-07-05T15:00:01+10:00 https://pharmadispatch.com/news/decisions-by-economists-or-oncologists 2018-07-04T15:00:01+10:00 https://pharmadispatch.com/news/shingles-vaccine-reminder 2018-07-04T15:00:01+10:00 https://pharmadispatch.com/news/government-exonerates-itself-on-confidentiality-breach 2018-07-04T15:10:01+10:00 https://pharmadispatch.com/news/consumers-back-pharmacy-on-service-and-regulation 2018-07-05T15:00:01+10:00 https://pharmadispatch.com/news/takeda-launches-australian-innovation-program 2018-07-05T15:00:01+10:00 https://pharmadispatch.com/news/ma-action-urgently-required-on-confidentiality 2018-07-05T15:10:01+10:00 https://pharmadispatch.com/news/ausbiotech-survey-reveals-record-sentiment 2018-07-06T15:00:01+10:00 https://pharmadispatch.com/news/private-research-is-not-a-legitimate-purpose 2018-07-06T15:00:01+10:00 https://pharmadispatch.com/news/auscann-completes-334-million-capital-raise 2018-07-06T15:00:01+10:00 https://pharmadispatch.com/news/the-power-of-one-letter 2018-07-06T15:00:01+10:00 https://pharmadispatch.com/news/cso-wholesalers-want-action-now 2018-07-09T15:00:01+10:00 https://pharmadispatch.com/news/who-is-this-third-party 2018-07-09T15:00:01+10:00 https://pharmadispatch.com/news/affirmative-action-required-for-rare-cancer-patients 2018-07-09T15:00:01+10:00 https://pharmadispatch.com/news/government-goes-again-on-deferrals 2018-07-09T15:00:01+10:00 https://pharmadispatch.com/news/benitec-secures-licensing-deal-for-gene-therapy 2018-07-10T15:00:01+10:00 https://pharmadispatch.com/news/janssen-welcomes-approval-through-regulatory-collaboration 2018-07-10T15:00:01+10:00 https://pharmadispatch.com/news/nhmrc-funding-for-prevention-research 2018-07-10T15:00:01+10:00 https://pharmadispatch.com/news/bionomics-reports-on-trial-progress 2018-07-10T15:00:01+10:00 https://pharmadispatch.com/news/click-here-for-more-confidentiality-or-less 2018-07-11T15:00:01+10:00 https://pharmadispatch.com/news/is-this-actually-serious-or-just-a-setup 2018-07-11T15:00:01+10:00 https://pharmadispatch.com/news/ma-welcomes-regulatory-collaboration 2018-07-11T15:00:01+10:00 https://pharmadispatch.com/news/clinical-trial-gives-new-hope-to-transplant-patients 2018-07-11T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-defers-price-increases-after-trump-intervention 2018-07-12T15:00:01+10:00 https://pharmadispatch.com/news/why-the-move-to-limit-scrutiny 2018-07-12T15:00:01+10:00 https://pharmadispatch.com/news/just-remember-to-ask 2018-07-12T15:05:01+10:00 https://pharmadispatch.com/news/ignore-doom-and-gloom-merchants 2018-07-12T15:00:01+10:00 https://pharmadispatch.com/news/someone-has-the-august-update 2018-07-13T15:00:01+10:00 https://pharmadispatch.com/news/nz-waiting-list-an-international-disgrace 2018-07-13T15:00:01+10:00 https://pharmadispatch.com/news/another-move-for-former-ma-chair 2018-07-13T05:51:01+10:00 https://pharmadispatch.com/news/npsa-the-time-for-action-is-now 2018-07-13T15:00:01+10:00 https://pharmadispatch.com/news/dusc-melanoma-adhd-and-eye-disease 2018-07-16T13:00:01+10:00 https://pharmadispatch.com/news/its-confidential-but-not-kind-of-is-it 2018-07-16T15:00:01+10:00 https://pharmadispatch.com/news/ma-in-melbourne-for-strategic-planning 2018-07-16T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-new-commercialisation-funding 2018-07-16T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-four-of-the-august-listings 2018-07-16T15:05:01+10:00 https://pharmadispatch.com/news/the-1bn-gift-from-gilead 2018-07-17T15:00:01+10:00 https://pharmadispatch.com/news/more-listings-for-august 2018-07-17T15:00:01+10:00 https://pharmadispatch.com/news/pharmacy-backs-my-health-record 2018-07-17T15:00:01+10:00 https://pharmadispatch.com/news/priceline-breaks-fundraising-record 2018-07-17T15:00:01+10:00 https://pharmadispatch.com/news/rare-cancers-launches-new-online-resource 2018-07-18T15:00:01+10:00 https://pharmadispatch.com/news/shipment-of-additional-adult-flu-vaccines-commences 2018-07-18T15:00:01+10:00 https://pharmadispatch.com/news/mundipharma-awards-fifth-annual-clinical-research-fellowship-1 2018-07-18T15:00:01+10:00 https://pharmadispatch.com/news/wa-scientists-develop-world-new-test-for-early-detection-of-mela 2018-07-18T15:00:01+10:00 https://pharmadispatch.com/news/the-sector-should-thank-gilead 2018-07-18T15:00:01+10:00 https://pharmadispatch.com/news/ma-working-on-long-term-plan 2018-07-19T15:00:01+10:00 https://pharmadispatch.com/news/rca-welcomes-investment-in-genome-sequencing 2018-07-19T15:00:01+10:00 https://pharmadispatch.com/news/bayer-reports-positive-news-on-xarelto 2018-07-19T15:00:01+10:00 https://pharmadispatch.com/news/fast-track-for-melbourne-company 2018-07-19T15:00:01+10:00 https://pharmadispatch.com/news/ma-to-appoint-new-independent-chair 2018-07-20T03:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-acknowledges-outgoing-ma-chair 2018-07-20T15:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-wants-action-on-unintended-consequence 2018-07-20T15:00:01+10:00 https://pharmadispatch.com/news/registrations-open-for-rca-canforum-2018 2018-07-20T15:00:01+10:00 https://pharmadispatch.com/news/new-leadership-but-not-a-new-challenge 2018-07-23T15:00:01+10:00 https://pharmadispatch.com/news/no-progress-as-compounders-push-alternative-model 2018-07-23T15:00:01+10:00 https://pharmadispatch.com/news/august-schedule-change-for-ivf-therapies 2018-07-23T15:00:01+10:00 https://pharmadispatch.com/news/does-not-meet-the-criteria-but-then-it-does 2018-07-23T15:05:01+10:00 https://pharmadispatch.com/news/hepatitis-australia-hopeful-of-a-response 2018-07-24T15:00:01+10:00 https://pharmadispatch.com/news/new-lease-of-life-for-mas-ceo-working-group 2018-07-24T15:00:01+10:00 https://pharmadispatch.com/news/asmi-marks-international-self-care-day 2018-07-24T15:00:01+10:00 https://pharmadispatch.com/news/fda-acting-to-encourage-biosimilar-market 2018-07-24T15:00:01+10:00 https://pharmadispatch.com/news/laborwill-include-pbs-in-reform-commission 2018-07-25T15:00:01+10:00 https://pharmadispatch.com/news/compounders-building-support-for-payment-model 2018-07-25T15:00:01+10:00 https://pharmadispatch.com/news/jj-partners-with-childrens-ground 2018-07-25T15:00:01+10:00 https://pharmadispatch.com/news/labor-calls-for-free-vaccine 2018-07-25T15:00:01+10:00 https://pharmadispatch.com/news/novartis-boss-departs-for-japan 2018-07-25T21:59:01+10:00 https://pharmadispatch.com/news/mayne-acquires-another-us-generic 2018-07-26T15:00:01+10:00 https://pharmadispatch.com/news/ma-set-to-fill-board-vacancy 2018-07-26T15:00:01+10:00 https://pharmadispatch.com/news/new-funding-for-ai-and-cancer-projects 2018-07-26T15:00:01+10:00 https://pharmadispatch.com/news/full-year-data-but-rebates-make-it-mostly-meaningless 2018-07-26T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-open-day-for-automotive-workers 2018-07-27T15:00:01+10:00 https://pharmadispatch.com/news/new-survey-medicine-use-not-quite-right 2018-07-27T15:00:01+10:00 https://pharmadispatch.com/news/bms-welcomes-new-opdivo-listing 2018-07-27T15:00:01+10:00 https://pharmadispatch.com/news/tasmanian-government-backs-pharmacy-for-vaccine-program 2018-07-27T15:00:01+10:00 https://pharmadispatch.com/news/abbvies-kirsten-odoherty-goal-is-to-reach-more-people-living-wit 2018-07-30T15:00:01+10:00 https://pharmadispatch.com/news/psa-looks-to-expanded-role-for-pharmacy 2018-07-30T15:00:01+10:00 https://pharmadispatch.com/news/workshop-for-industry-gender-equity-group 2018-07-30T15:00:01+10:00 https://pharmadispatch.com/news/government-moves-to-address-hcv-treatment-decline 2018-07-30T15:00:01+10:00 https://pharmadispatch.com/news/novo-nordisk-welcomes-first-listing-in-12-years 2018-07-30T15:00:01+10:00 https://pharmadispatch.com/news/the-real-impact-of-the-deferral-policy 2018-07-31T15:00:01+10:00 https://pharmadispatch.com/news/australian-company-progresses-eye-therapy 2018-07-31T15:00:01+10:00 https://pharmadispatch.com/news/regeneus-reports-on-cancer-vaccine-trial 2018-07-31T15:00:01+10:00 https://pharmadispatch.com/news/cochlear-completes-final-phase-of-new-brisbane-site 2018-07-31T15:00:01+10:00 https://pharmadispatch.com/news/building-the-dream-or-living-in-la-la-land-pbs-reform-10-years-o 2018-08-01T15:00:01+10:00 https://pharmadispatch.com/news/gbma-announces-biosimilar-national-awareness-week 2018-08-01T15:00:01+10:00 https://pharmadispatch.com/news/page-leadership-pay-gap-and-flexibility 2018-08-01T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-the-latest-to-confirm-magnitude-of-us-rebates 2018-08-01T15:00:01+10:00 https://pharmadispatch.com/news/industry-needs-to-know-what-it-wants 2018-08-02T15:00:01+10:00 https://pharmadispatch.com/news/ma-pushing-addendum-to-national-medicines-policy 2018-08-02T15:00:01+10:00 https://pharmadispatch.com/news/low-cholesterol-should-be-even-lower 2018-08-02T15:00:01+10:00 https://pharmadispatch.com/news/australias-first-guidelines-on-atrial-fibrillation 2018-08-02T15:00:01+10:00 https://pharmadispatch.com/news/ma-exclusive-critical-to-build-a-renewed-momentum 2018-08-02T15:00:01+10:00 https://pharmadispatch.com/news/confidentially-this-is-absolutely-confidential 2018-08-03T15:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-questions-ma-approach-to-national-medicines-policy 2018-08-03T15:00:01+10:00 https://pharmadispatch.com/news/bi-and-lilly-welcome-new-guidelines 2018-08-03T15:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-cost-of-heart-disease 2018-08-03T15:00:01+10:00 https://pharmadispatch.com/news/nz-appoints-ex-cabinet-minister-to-chair-pharmac 2018-08-06T15:00:01+10:00 https://pharmadispatch.com/news/driven-by-the-profound-unmet-needs-of-patients 2018-08-06T15:00:01+10:00 https://pharmadispatch.com/news/companies-extend-uk-supply-as-industry-warns-on-brexit 2018-08-06T15:00:01+10:00 https://pharmadispatch.com/news/could-reference-pricing-be-an-emerging-battle 2018-08-06T15:01:01+10:00 https://pharmadispatch.com/news/confidentiality-at-risk-of-hindering-consultation-and-outcomes 2018-08-07T15:00:01+10:00 https://pharmadispatch.com/news/pharmaxis-completes-successful-capital-raise 2018-08-07T15:00:01+10:00 https://pharmadispatch.com/news/vial-sharing-a-factor-in-debate-over-new-payment-system 2018-08-07T15:00:01+10:00 https://pharmadispatch.com/news/recognition-for-impact-of-medicines-study 2018-08-07T15:00:01+10:00 https://pharmadispatch.com/news/bayer-backing-heart-of-australia 2018-08-08T15:00:01+10:00 https://pharmadispatch.com/news/lundbeck-progresses-development-of-its-first-antibody 2018-08-08T03:00:01+10:00 https://pharmadispatch.com/news/companies-vial-sharing-could-put-patient-safety-at-risk 2018-08-08T15:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-rankings-confirm-commercialisation-the-issue 2018-08-08T15:00:01+10:00 https://pharmadispatch.com/news/allcan-launches-cancer-patient-survey 2018-08-09T15:00:01+10:00 https://pharmadispatch.com/news/csanz-announces-bayer-supported-grant-recipients 2018-08-09T03:26:01+10:00 https://pharmadispatch.com/news/sector-gathers-for-labors-business-forum 2018-08-09T15:00:01+10:00 https://pharmadispatch.com/news/ex-roche-executive-to-lead-qimr-spin-out 2018-08-08T15:00:01+10:00 https://pharmadispatch.com/news/theres-another-word-for-maximising-drug-cost-efficiencies 2018-08-10T15:00:01+10:00 https://pharmadispatch.com/news/industry-facing-a-new-confidentiality-breach 2018-08-10T15:00:01+10:00 https://pharmadispatch.com/news/pfizer-launches-local-open-chapter 2018-08-10T05:38:01+10:00 https://pharmadispatch.com/news/biotron-updates-on-proof-of-concept-trial 2018-08-10T15:00:01+10:00 https://pharmadispatch.com/news/the-monetisation-of-vial-sharing 2018-08-13T15:00:01+10:00 https://pharmadispatch.com/news/department-of-health-responds-on-new-confidentiality-rift 2018-08-13T15:00:01+10:00 https://pharmadispatch.com/news/exclusive-a-unique-team-and-powerful-combination 2018-08-13T15:05:01+10:00 https://pharmadispatch.com/news/ma-announces-new-chair 2018-08-13T15:04:01+10:00 https://pharmadispatch.com/news/survey-reveals-consumers-spending-200m-on-cancer-medicines 2018-08-14T15:00:01+10:00 https://pharmadispatch.com/news/shpa-optimal-health-outcomes-and-economic-objectives 2018-08-14T15:00:01+10:00 https://pharmadispatch.com/news/australians-back-pharmacy-vaccinations 2018-08-14T15:00:01+10:00 https://pharmadispatch.com/news/abbvie-part-of-investment-in-northern-qld-biotech 2018-08-14T15:00:01+10:00 https://pharmadispatch.com/news/merck-biopharma-confirms-new-australian-leader 2018-08-14T15:00:01+10:00 https://pharmadispatch.com/news/transparency-is-the-first-step 2018-08-15T15:00:01+10:00 https://pharmadispatch.com/news/vertex-working-towards-reimbursement 2018-08-15T02:52:01+10:00 https://pharmadispatch.com/news/tga-approval-for-allergan-eye-implant 2018-08-15T15:00:01+10:00 https://pharmadispatch.com/news/pfizers-celebrity-doctor-on-humanising-the-industry 2018-08-16T15:00:01+10:00 https://pharmadispatch.com/news/patient-access-at-risk-over-pbac-fee-waiver 2018-08-16T15:00:01+10:00 https://pharmadispatch.com/news/investors-cheer-csl-result-and-outlook 2018-08-16T15:00:01+10:00 https://pharmadispatch.com/news/fda-approval-for-pharmaxis-manufacturing-facility 2018-08-16T15:00:01+10:00 https://pharmadispatch.com/news/government-unhappy-as-big-day-arrives 2018-08-17T15:00:01+10:00 https://pharmadispatch.com/news/orphan-designation-change-another-barrier 2018-08-17T15:00:01+10:00 https://pharmadispatch.com/news/industry-firmly-split-on-rebate-reform-model 2018-08-17T15:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-any-change-ultimately-a-matter-for-government 2018-08-17T15:05:01+10:00 https://pharmadispatch.com/news/seven-candidates-for-ma-board-vacancy 2018-08-20T15:00:01+10:00 https://pharmadispatch.com/news/july-pbac-immunotherapies-biosimilars-and-cystic-fibrosis 2018-08-20T15:00:01+10:00 https://pharmadispatch.com/news/documents-reveal-more-on-confidentiality-controversy 2018-08-20T15:00:01+10:00 https://pharmadispatch.com/news/evidence-of-a-deliberate-work-around 2018-08-20T15:00:01+10:00 https://pharmadispatch.com/news/how-can-this-be-privileged 2018-08-21T14:00:01+10:00 https://pharmadispatch.com/news/documents-are-full-of-irony 2018-08-21T14:00:01+10:00 https://pharmadispatch.com/news/doubts-re-emerge-over-the-ags-investigation 2018-08-21T14:00:01+10:00 https://pharmadispatch.com/news/department-confirms-permanent-appointment 2018-08-21T14:00:01+10:00 https://pharmadispatch.com/news/candidates-start-making-their-case 2018-08-21T14:00:01+10:00 https://pharmadispatch.com/news/ma-pre-empt-to-avoid-surprises 2018-08-22T14:00:01+10:00 https://pharmadispatch.com/news/sector-facing-its-now-what-moment 2018-08-22T14:00:01+10:00 https://pharmadispatch.com/news/pfizers-melissa-mcgregor-how-were-working-today-and-tomorrow 2018-08-22T14:00:01+10:00 https://pharmadispatch.com/news/new-report-reveals-impact-of-new-ms-treatments 2018-08-22T14:00:01+10:00 https://pharmadispatch.com/news/recommended-but-not-listing-any-time-soon 2018-08-23T15:00:01+10:00 https://pharmadispatch.com/news/insights-from-msds-michael-azrak 2018-08-23T15:00:01+10:00 https://pharmadispatch.com/news/timing-a-challenge-at-november-pbac 2018-08-23T15:00:01+10:00 https://pharmadispatch.com/news/patients-welcome-new-migraine-option 2018-08-23T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-resigns-as-leadership-comes-to-a-head 2018-08-23T21:04:01+10:00 https://pharmadispatch.com/news/azs-chatwin-time-for-a-new-approach 2018-08-24T15:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-launches-2018-value-of-medicines-award 2018-08-24T15:00:01+10:00 https://pharmadispatch.com/news/neuren-receives-initial-payment-from-acadia 2018-08-24T15:00:01+10:00 https://pharmadispatch.com/news/ebos-reports-earnings-jump-despite-pbs-reforms-and-hcv-decline 2018-08-24T15:00:01+10:00 https://pharmadispatch.com/news/no-health-ministers-in-new-leadership 2018-08-24T22:00:01+10:00 https://pharmadispatch.com/news/from-will-to-can-and-now-conditional-criteria 2018-08-27T15:00:01+10:00 https://pharmadispatch.com/news/minister-reappointed-but-things-will-be-different 2018-08-27T15:00:01+10:00 https://pharmadispatch.com/news/biogen-welcomes-medsafe-approval-of-spinraza 2018-08-27T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-reappointed-to-health-portfolio 2018-08-26T23:34:01+10:00 https://pharmadispatch.com/news/global-vision-for-specialised-therapeutics 2018-08-27T15:00:01+10:00 https://pharmadispatch.com/news/companies-gather-for-urgent-meeting-on-price-cut-guidelines 2018-08-28T15:00:01+10:00 https://pharmadispatch.com/news/what-did-the-minister-say 2018-08-28T15:00:01+10:00 https://pharmadispatch.com/news/winners-of-jj-victorian-quickfire-challenge 2018-08-28T15:00:01+10:00 https://pharmadispatch.com/news/ma-ceo-association-will-act-to-address-price-cut-guidelines 2018-08-28T15:00:01+10:00 https://pharmadispatch.com/news/us-secures-major-data-protection-victory 2018-08-29T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-honoured-and-humbled-to-be-reappointed 2018-08-29T15:00:01+10:00 https://pharmadispatch.com/news/this-is-not-a-legal-issue-it-is-about-a-written-signed-and-state 2018-08-29T15:00:01+10:00 https://pharmadispatch.com/news/patrys-teams-up-with-walter-and-eliza-hall-institute 2018-08-29T15:00:01+10:00 https://pharmadispatch.com/news/what-does-a-variation-mean 2018-08-30T15:00:01+10:00 https://pharmadispatch.com/news/another-day-another-problem 2018-08-30T15:00:01+10:00 https://pharmadispatch.com/news/viiv-announces-grants-for-hiv-community-programs 2018-08-30T15:00:01+10:00 https://pharmadispatch.com/news/abbvie-wins-recognition 2018-08-30T15:00:01+10:00 https://pharmadispatch.com/news/gsk-launches-new-reconciliation-action-plan 2018-08-31T15:00:01+10:00 https://pharmadispatch.com/news/minister-to-announce-members-of-lsdp-expert-panel 2018-08-31T15:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-hcp-payment-reports 2018-08-31T15:00:01+10:00 https://pharmadispatch.com/news/a-system-that-has-become-about-winners-and-losers 2018-09-03T15:00:01+10:00 https://pharmadispatch.com/news/trump-agree-or-canada-will-be-out 2018-09-03T15:00:01+10:00 https://pharmadispatch.com/news/pharmadispatch-2019-first-two-international-speakers 2018-09-03T15:00:01+10:00 https://pharmadispatch.com/news/vertex-welcomes-accelerated-orkambi-listing 2018-09-03T15:00:01+10:00 https://pharmadispatch.com/news/the-dire-consequences-of-winners-and-losers 2018-09-03T15:00:01+10:00 https://pharmadispatch.com/news/sta-welcomes-expanded-listing-for-iclusig 2018-09-03T15:00:01+10:00 https://pharmadispatch.com/news/change-required-to-ensure-patient-voice 2018-09-04T14:00:01+10:00 https://pharmadispatch.com/news/ausbiotech-ceo-lorraine-chiroiu-on-early-impressions-and-future- 2018-09-04T14:00:01+10:00 https://pharmadispatch.com/news/psa-still-seeking-feedback-on-discussion-paper 2018-09-04T14:00:01+10:00 https://pharmadispatch.com/news/pfizer-welcomes-exchange-students-to-sydney-hq 2018-09-04T14:00:01+10:00 https://pharmadispatch.com/news/waiting-for-progress-as-implementation-day-approaches 2018-09-05T14:02:01+10:00 https://pharmadispatch.com/news/polyactiva-recruits-first-patient-in-new-study 2018-09-05T14:01:01+10:00 https://pharmadispatch.com/news/labor-to-re-establish-key-industry-pbs-dialogue 2018-09-05T14:02:01+10:00 https://pharmadispatch.com/news/kim-carr-dont-fall-for-the-three-card-trick 2018-09-05T14:05:01+10:00 https://pharmadispatch.com/news/ma-hosts-all-day-policy-meeting 2018-09-06T15:00:01+10:00 https://pharmadispatch.com/news/has-it-ever-been-more-important 2018-09-06T15:00:01+10:00 https://pharmadispatch.com/news/ma-appoints-ex-labor-staffer-to-lead-public-affairs 2018-09-06T15:00:01+10:00 https://pharmadispatch.com/news/industry-backs-labor-on-piwg 2018-09-06T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-loses-key-staffer 2018-09-07T14:00:01+10:00 https://pharmadispatch.com/news/sigma-profit-falls-but-sticks-with-guidance 2018-09-07T14:00:01+10:00 https://pharmadispatch.com/news/optheas-opt-302-trial-to-continue-after-positive-review 2018-09-07T14:00:01+10:00 https://pharmadispatch.com/news/starting-the-process-of-re-engagement 2018-09-07T14:00:01+10:00 https://pharmadispatch.com/news/medicines-australia-companies-elect-new-board-member 2018-09-08T03:30:01+10:00 https://pharmadispatch.com/news/could-six-become-seven-before-the-end-of-2018 2018-09-10T15:00:01+10:00 https://pharmadispatch.com/news/ma-price-cut-guidelines-will-be-revised 2018-09-10T15:00:01+10:00 https://pharmadispatch.com/news/uk-hits-back-at-industry-over-pricing 2018-09-10T15:00:01+10:00 https://pharmadispatch.com/news/new-collaboration-for-melbournes-monash 2018-09-10T15:00:01+10:00 https://pharmadispatch.com/news/labor-moves-back-to-health 2018-09-10T15:00:01+10:00 https://pharmadispatch.com/news/still-no-agreement-on-payment-model-as-clock-ticks 2018-09-11T15:00:01+10:00 https://pharmadispatch.com/news/an-issue-that-will-not-simply-go-away 2018-09-11T15:00:01+10:00 https://pharmadispatch.com/news/stakeholders-gather-for-canforum-2018 2018-09-11T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-its-all-about-access-to-medicines 2018-09-11T15:00:01+10:00 https://pharmadispatch.com/news/mandatory-reporting-as-companies-face-demands-for-preferential-t 2018-09-12T15:00:01+10:00 https://pharmadispatch.com/news/unity-on-potential-change-to-orphan-drug-limit 2018-09-12T15:00:01+10:00 https://pharmadispatch.com/news/bi-secures-change-for-pradaxa 2018-09-12T15:00:01+10:00 https://pharmadispatch.com/news/catherine-king-sustainable-funding-a-priority 2018-09-12T15:00:01+10:00 https://pharmadispatch.com/news/msd-welcomes-hr-recognition 2018-09-13T15:00:01+10:00 https://pharmadispatch.com/news/biomarin-hopeful-as-therapy-navigates-new-lsdp-process 2018-09-13T15:00:01+10:00 https://pharmadispatch.com/news/sydney-based-cellmid-announces-positive-trial-result 2018-09-13T15:00:01+10:00 https://pharmadispatch.com/news/more-speakers-confirmed-for-pharmadispatch-2019 2018-09-13T15:00:01+10:00 https://pharmadispatch.com/news/ma-moving-house-after-15-years 2018-09-14T15:00:01+10:00 https://pharmadispatch.com/news/health-still-ranks-1-issue-for-australians 2018-09-14T15:00:01+10:00 https://pharmadispatch.com/news/urbulence-early-impressions-priorities-policy-leadership-and-a-n 2018-09-14T15:00:01+10:00 https://pharmadispatch.com/news/industry-to-gather-for-pharmaus18 2018-09-14T03:49:01+10:00 https://pharmadispatch.com/news/no-parallel-process-for-biosimilars 2018-09-17T15:00:01+10:00 https://pharmadispatch.com/news/us-secures-pricing-policy-changes-from-korea 2018-09-17T15:00:01+10:00 https://pharmadispatch.com/news/ma-sponsored-report-highlights-economic-impact-of-early-retireme 2018-09-17T15:00:01+10:00 https://pharmadispatch.com/news/industry-veteran-to-launch-new-consultancy 2018-09-17T15:00:01+10:00 https://pharmadispatch.com/news/expanded-listings-for-celgene-and-roche-cancer-medicines 2018-09-17T15:00:01+10:00 https://pharmadispatch.com/news/andrew-wilson-not-a-numbers-game 2018-09-17T21:37:01+10:00 https://pharmadispatch.com/news/catherine-king-promotes-legislated-medicines-fund 2018-09-18T15:00:01+10:00 https://pharmadispatch.com/news/pbs-will-not-pick-up-the-cost-of-bad-investment-decisions 2018-09-18T15:00:01+10:00 https://pharmadispatch.com/news/csl-behring-welcomes-new-approval 2018-09-18T15:00:01+10:00 https://pharmadispatch.com/news/di-natale-thank-you-for-the-work-that-you-do 2018-09-18T15:00:01+10:00 https://pharmadispatch.com/news/promotion-for-former-lundbeck-australia-boss 2018-09-19T15:00:01+10:00 https://pharmadispatch.com/news/consumers-central-to-any-review-of-national-medicines-policy 2018-09-19T15:00:01+10:00 https://pharmadispatch.com/news/opthea-initiates-first-australian-patients-in-dme-trial 2018-09-19T15:00:01+10:00 https://pharmadispatch.com/news/it-really-is-about-getting-the-basics-right 2018-09-19T15:00:01+10:00 https://pharmadispatch.com/news/a-subtle-shift-might-be-more-likely-than-re-regulation 2018-09-20T15:00:01+10:00 https://pharmadispatch.com/news/mundipharma-welcomes-registration-of-naloxone-nasal-spray 2018-09-20T15:00:01+10:00 https://pharmadispatch.com/news/first-new-malaria-treatment-in-two-decades 2018-09-20T15:00:01+10:00 https://pharmadispatch.com/news/former-industry-leaders-join-china-incubator 2018-09-20T15:00:01+10:00 https://pharmadispatch.com/news/government-to-review-nps-medicinewise 2018-09-21T15:00:01+10:00 https://pharmadispatch.com/news/medicines-nz-2018-value-of-medicines-award 2018-09-21T15:00:01+10:00 https://pharmadispatch.com/news/apotex-arrow-merger-to-close-by-end-of-year 2018-09-21T15:00:01+10:00 https://pharmadispatch.com/news/us-business-leaders-pushing-for-stronger-ip 2018-09-21T15:00:01+10:00 https://pharmadispatch.com/news/uk-industry-slams-court-decision-on-unapproved-use 2018-09-24T15:00:01+10:00 https://pharmadispatch.com/news/the-commercialisation-of-nps-medicinewise 2018-09-24T15:01:01+10:00 https://pharmadispatch.com/news/the-challenge-for-an-evolving-organisation 2018-09-24T15:00:01+10:00 https://pharmadispatch.com/news/opdivo-secures-approval-for-11th-indication 2018-09-24T15:00:01+10:00 https://pharmadispatch.com/news/gsk-and-mmv-announce-kozenis-approval 2018-09-24T15:00:01+10:00 https://pharmadispatch.com/news/what-would-be-the-reaction 2018-09-28T15:00:01+10:00 https://pharmadispatch.com/news/review-will-involve-public-consultation 2018-09-25T15:00:01+10:00 https://pharmadispatch.com/news/you-just-read-it-and-laugh-out-loud 2018-09-25T15:00:01+10:00 https://pharmadispatch.com/news/msd-raises-money-for-drought-affected-communities 2018-09-25T15:00:01+10:00 https://pharmadispatch.com/news/greg-hunt-announces-new-vaccine-funding 2018-09-25T15:00:01+10:00 https://pharmadispatch.com/news/different-presentation-different-result-on-pbs-spend 2018-09-25T22:44:01+10:00 https://pharmadispatch.com/news/the-pbs-as-collateral-damage 2018-09-26T15:00:01+10:00 https://pharmadispatch.com/news/two-decades-of-reform-based-on-a-false-premise 2018-09-27T15:00:01+10:00 https://pharmadispatch.com/news/higher-fees-for-new-processes-based-on-submission-categories 2018-09-26T15:00:01+10:00 https://pharmadispatch.com/news/allergan-goes-artistic-to-mark-50-years-in-australia 2018-09-26T15:00:01+10:00 https://pharmadispatch.com/news/new-australian-collaboration-for-merck-and-pfizers-immunotherapy 2018-09-26T15:00:01+10:00 https://pharmadispatch.com/news/mundipharmas-jane-orr-company-open-to-possibilities 2018-09-26T15:00:01+10:00 https://pharmadispatch.com/news/new-process-gives-pbac-power-to-prioritise 2018-09-27T15:00:01+10:00 https://pharmadispatch.com/news/registrations-open-for-pharmadispatch-2019 2018-09-27T15:00:01+10:00 https://pharmadispatch.com/news/lilly-backs-recognition-for-diabetes-educator 2018-09-27T15:00:01+10:00 https://pharmadispatch.com/news/pbac-chair-more-work-to-be-done-on-processes 2018-09-28T15:00:01+10:00 https://pharmadispatch.com/news/industry-bodies-unite-ahead-of-victorian-election 2018-09-28T15:00:01+10:00 https://pharmadispatch.com/news/allergan-marks-50-years-with-pop-up-gallery 2018-09-28T15:00:01+10:00 https://pharmadispatch.com/news/ministers-confirm-government-sticking-with-cost-offset-rule 2018-10-02T13:00:01+10:00 https://pharmadispatch.com/news/one-third-of-consumer-spending-on-other-medicines 2018-10-01T13:00:01+10:00 https://pharmadispatch.com/news/phased-implementation-to-overcome-sector-disagreement 2018-10-03T15:00:01+10:00 https://pharmadispatch.com/news/final-guidelines-reveal-minor-changes 2018-10-02T13:00:01+10:00 https://pharmadispatch.com/news/canada-backs-pharma-ip-extension 2018-10-02T13:00:01+10:00 https://pharmadispatch.com/news/new-submission-process-key-to-any-pan-tumour-change 2018-10-02T13:00:01+10:00 https://pharmadispatch.com/news/pfizer-announces-ceo-succession 2018-10-02T13:00:01+10:00 https://pharmadispatch.com/news/what-happens-if-the-us-targets-australia 2018-10-03T15:00:01+10:00 https://pharmadispatch.com/news/melbourne-based-biotron-reports-positive-results-from-phase-2-hi 2018-10-03T15:00:01+10:00 https://pharmadispatch.com/news/nobel-prize-for-immunotherapy-scientists 2018-10-03T15:00:01+10:00 https://pharmadispatch.com/news/bms-system-needs-to-do-better 2018-10-03T15:00:01+10:00 https://pharmadispatch.com/news/new-chair-starts-for-mtpconnect 2018-10-04T15:00:01+10:00 https://pharmadispatch.com/news/msd-pan-tumour-a-once-in-a-generation-opportunity 2018-10-04T15:00:01+10:00 https://pharmadispatch.com/news/ma-backs-ip-changes-in-response-to-us-trade-push 2018-10-04T15:00:01+10:00 https://pharmadispatch.com/news/gsk-announces-plan-to-ease-payment-ban 2018-10-04T15:00:01+10:00 https://pharmadispatch.com/news/new-patient-support-organisation-focused-on-gaucher-disease 2018-10-05T14:00:01+10:00 https://pharmadispatch.com/news/extended-listing-for-janssens-simponi 2018-10-05T14:00:01+10:00 https://pharmadispatch.com/news/new-study-highlights-impact-of-hpv-vaccine 2018-10-05T14:00:01+10:00 https://pharmadispatch.com/news/ma-review-cross-subsidisation-model 2018-10-05T14:00:01+10:00 https://pharmadispatch.com/news/gst-highlights-complexity-of-new-payment-system 2018-10-08T15:00:01+11:00 https://pharmadispatch.com/news/no-progress-on-spa-review 2018-10-08T15:00:01+11:00 https://pharmadispatch.com/news/pharmadispatch-2019-post-election-political-implications 2018-10-08T15:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-funding-for-trial-of-new-stroke-treatment 2018-10-07T16:00:01+11:00 https://pharmadispatch.com/news/novartis-to-host-world-hospital-congress-symposium 2018-10-08T15:00:01+11:00 https://pharmadispatch.com/news/gsk-extends-parental-leave-benefits 2018-10-09T16:00:01+11:00 https://pharmadispatch.com/news/investors-cheer-new-green-whistle-deal 2018-10-09T16:00:01+11:00 https://pharmadispatch.com/news/who-remembers-the-vancouver-poster 2018-10-08T16:00:01+11:00 https://pharmadispatch.com/news/new-spinraza-data-points-to-earlier-treatment 2018-10-09T16:00:01+11:00 https://pharmadispatch.com/news/emerging-sense-of-disillusion-about-agreement 2018-10-10T16:00:01+11:00 https://pharmadispatch.com/news/csl-donates-to-indonesia-earthquake 2018-10-10T16:00:01+11:00 https://pharmadispatch.com/news/at-least-its-better-than-portugal 2018-10-10T16:00:01+11:00 https://pharmadispatch.com/news/psa-welcomes-royal-commission-terms-of-reference 2018-10-10T16:00:01+11:00 https://pharmadispatch.com/news/department-of-health-confirms-taa-leadership 2018-10-11T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-launches-2018-21-strategic-plan 2018-10-11T16:00:01+11:00 https://pharmadispatch.com/news/sector-awaits-cso-review-outcome 2018-10-11T16:00:01+11:00 https://pharmadispatch.com/news/abbvie-hosts-cancer-moonshot-seminar 2018-10-11T16:00:01+11:00 https://pharmadispatch.com/news/lillys-libby-driscoll-not-just-another-headache 2018-10-15T13:00:01+11:00 https://pharmadispatch.com/news/two-down-as-pfizer-settles-pbs-damages-case 2018-10-12T15:00:01+11:00 https://pharmadispatch.com/news/us-bans-drug-gag-orders 2018-10-12T15:00:01+11:00 https://pharmadispatch.com/news/guild-welcomes-faster-business-tax-cuts 2018-10-12T15:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-moving-on-car-t-access 2018-10-12T15:00:01+11:00 https://pharmadispatch.com/news/csl-announces-fellowship-recipients 2018-10-12T15:00:01+11:00 https://pharmadispatch.com/news/the-burden-of-migraine 2018-10-15T13:00:01+11:00 https://pharmadispatch.com/news/pharmacy-backs-national-consistency-on-vaccination 2018-10-15T13:00:01+11:00 https://pharmadispatch.com/news/abbvie-secures-another-humira-victory 2018-10-15T13:00:01+11:00 https://pharmadispatch.com/news/cancer-services-covered-across-all-phi-categories 2018-10-15T13:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-bristol-myers-squibb 2018-10-16T13:00:01+11:00 https://pharmadispatch.com/news/annual-cost-of-migraine-tops-35-billion 2018-10-16T13:00:01+11:00 https://pharmadispatch.com/news/labor-moves-to-block-trade-related-pbs-changes 2018-10-16T13:00:01+11:00 https://pharmadispatch.com/news/annual-report-reveals-faster-response-times 2018-10-16T13:00:01+11:00 https://pharmadispatch.com/news/rebates-fall-but-net-spending-up 2018-10-16T22:19:01+11:00 https://pharmadispatch.com/news/annual-report-confirms-red-flags-for-pbs 2018-10-17T13:00:01+11:00 https://pharmadispatch.com/news/abbvie-makes-global-top-25-best-place-to-work 2018-10-17T13:00:01+11:00 https://pharmadispatch.com/news/psa-welcomes-queensland-inquiry-recommendations 2018-10-17T13:00:01+11:00 https://pharmadispatch.com/news/three-down-from-lundbeck-in-lexapro-patent-case 2018-10-17T13:00:01+11:00 https://pharmadispatch.com/news/companies-repay-1-in-5-pbs-dollars 2018-10-18T13:00:01+11:00 https://pharmadispatch.com/news/abbvie-welcomes-new-venclexta-approval 2018-10-18T13:00:01+11:00 https://pharmadispatch.com/news/canadian-government-faces-scrutiny-over-data-protection-extensio 2018-10-18T13:00:01+11:00 https://pharmadispatch.com/news/no-share-split-for-csl 2018-10-18T13:00:01+11:00 https://pharmadispatch.com/news/guild-backs-government-intervention-on-entitlements 2018-10-19T12:00:01+11:00 https://pharmadispatch.com/news/parliament-backs-tpp-legislation 2018-10-19T12:00:01+11:00 https://pharmadispatch.com/news/merck-gets-behind-national-carers-week 2018-10-19T12:00:01+11:00 https://pharmadispatch.com/news/two-key-industry-appointments 2018-10-19T12:00:01+11:00 https://pharmadispatch.com/news/abbvie-launches-discover-series 2018-10-19T12:00:01+11:00 https://pharmadispatch.com/news/api-highlights-impact-of-direct-distribution-in-results 2018-10-19T12:00:01+11:00 https://pharmadispatch.com/news/complicating-the-already-complicated 2018-10-22T16:00:01+11:00 https://pharmadispatch.com/news/companies-start-contemplating-caretaker 2018-10-22T16:00:01+11:00 https://pharmadispatch.com/news/industry-nerves-on-special-pricing-arrangements 2018-10-22T16:00:01+11:00 https://pharmadispatch.com/news/companies-join-walk-to-end-stigma 2018-10-22T16:00:01+11:00 https://pharmadispatch.com/news/ma-to-consider-new-board-vacancy 2018-10-23T16:00:01+11:00 https://pharmadispatch.com/news/new-study-backs-keytruda-in-bladder-cancer 2018-10-23T16:00:01+11:00 https://pharmadispatch.com/news/msd-progress-on-biosimilar-uptake-but-more-required 2018-10-23T16:00:01+11:00 https://pharmadispatch.com/news/so-who-is-responsible-for-the-pbs 2018-10-23T16:00:01+11:00 https://pharmadispatch.com/news/call-for-action-on-lung-cancer 2018-10-24T13:00:01+11:00 https://pharmadispatch.com/news/advance-rebate-payments-as-new-deeds-impose-reform 2018-10-24T13:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-welcomes-new-senate-inquiry 2018-10-24T13:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-starts-november-listing-announcements 2018-10-24T16:00:01+11:00 https://pharmadispatch.com/news/health-insurers-reveal-high-cost-cancer-claims 2018-10-25T16:00:01+11:00 https://pharmadispatch.com/news/inn-prescribing-in-2019 2018-10-25T16:00:01+11:00 https://pharmadispatch.com/news/one-million-australians-at-risk-of-iron-deficiency 2018-10-25T16:00:01+11:00 https://pharmadispatch.com/news/officials-acknowledge-there-is-not-a-new-listing-every-day 2018-10-25T16:00:01+11:00 https://pharmadispatch.com/news/still-not-sharing-cost-recovery-modelling 2018-10-26T16:00:01+11:00 https://pharmadispatch.com/news/industry-seeking-nominations-for-pbac-appointment 2018-10-26T16:00:01+11:00 https://pharmadispatch.com/news/for-how-long-can-the-new-fund-distribution-of-the-old 2018-10-29T15:00:01+11:00 https://pharmadispatch.com/news/ma-welcomes-governments-mou-with-us-medical-research-leader 2018-10-26T16:00:01+11:00 https://pharmadispatch.com/news/nsw-extends-pharmacy-administered-vaccines 2018-10-26T16:00:01+11:00 https://pharmadispatch.com/news/az-backing-schools-based-food-program 2018-10-29T15:00:01+11:00 https://pharmadispatch.com/news/a-new-face-for-medicines-australia-board 2018-10-29T16:00:01+11:00 https://pharmadispatch.com/news/court-delivers-outcome-on-venlafaxine-damages 2018-10-29T15:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-announces-more-november-listings 2018-10-29T15:00:01+11:00 https://pharmadispatch.com/news/new-documents-reveal-impact-of-humira-biosimilars 2018-10-29T15:00:01+11:00 https://pharmadispatch.com/news/psa-partners-on-6cpa-program-administration 2018-10-29T20:26:01+11:00 https://pharmadispatch.com/news/us-move-to-international-reference-pricing 2018-10-30T16:00:01+11:00 https://pharmadispatch.com/news/court-orders-damages-over-venlafaxine-injunction 2018-10-30T16:00:01+11:00 https://pharmadispatch.com/news/further-evidence-of-disagreement-over-new-payment-system 2018-10-30T16:00:01+11:00 https://pharmadispatch.com/news/az-launches-school-based-food-program 2018-10-30T16:00:01+11:00 https://pharmadispatch.com/news/pku-patients-hopeful-on-access-to-treatment 2018-10-31T16:00:01+11:00 https://pharmadispatch.com/news/biocurate-signs-first-pharma-agreement-with-novartis 2018-10-31T16:00:01+11:00 https://pharmadispatch.com/news/industry-unsure-on-any-agreement-extension 2018-10-31T16:00:01+11:00 https://pharmadispatch.com/news/lauren-carey-car-t-requires-a-paradigm-shift 2018-10-31T16:00:01+11:00 https://pharmadispatch.com/news/constant-work-to-evolve-funding-systems 2018-11-05T16:00:01+11:00 https://pharmadispatch.com/news/ex-ma-boss-chasing-pre-selection 2018-11-01T16:00:01+11:00 https://pharmadispatch.com/news/a-big-day-for-amicus-therapeutics-in-australia 2018-11-01T16:00:01+11:00 https://pharmadispatch.com/news/new-report-highlights-regenerative-medicine-opportunity 2018-11-01T16:00:01+11:00 https://pharmadispatch.com/news/recognition-for-dr-anna-lavelle 2018-11-01T16:00:01+11:00 https://pharmadispatch.com/news/takeda-announces-cockpi-t-australia-2018-research-grants 2018-11-01T16:00:01+11:00 https://pharmadispatch.com/news/perpetual-announces-new-biomedical-research-awards 2018-11-02T16:00:01+11:00 https://pharmadispatch.com/news/exclusive-ey-report-on-payment-model-skips-vial-sharing 2018-11-02T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-confirms-board-line-up-at-agm 2018-11-02T16:00:01+11:00 https://pharmadispatch.com/news/ma-challenges-escrow-model 2018-11-02T16:00:01+11:00 https://pharmadispatch.com/news/pharma-facing-period-of-uncertainty-and-change 2018-11-05T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-highlights-success-of-national-conference 2018-11-05T16:00:01+11:00 https://pharmadispatch.com/news/give-pharmaceuticals-bespoke-chapter 2018-11-05T03:37:01+11:00 https://pharmadispatch.com/news/dusc-reports-on-hcv-uptake 2018-11-05T16:00:01+11:00 https://pharmadispatch.com/news/is-priority-a-good-word-when-it-comes-to-the-pbs 2018-11-06T16:00:01+11:00 https://pharmadispatch.com/news/nps-grows-non-government-revenue 2018-11-06T16:00:01+11:00 https://pharmadispatch.com/news/pbs-not-the-only-program-with-a-payment-lag 2018-11-06T16:00:01+11:00 https://pharmadispatch.com/news/under-co-pay-market-still-growing-strongly 2018-11-06T16:00:01+11:00 https://pharmadispatch.com/news/another-example-of-prioritisation 2018-11-07T16:00:01+11:00 https://pharmadispatch.com/news/ma-concerned-if-submission-pathways-re-purposed 2018-11-07T16:00:01+11:00 https://pharmadispatch.com/news/nps-review-underway-but-more-to-come 2018-11-07T16:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-extends-alliance-with-mtpconnect 2018-11-07T16:19:01+11:00 https://pharmadispatch.com/news/does-it-make-the-system-better-for-patients 2018-11-08T16:00:01+11:00 https://pharmadispatch.com/news/industry-experts-guide-researchers-and-entrepreneurs 2018-11-08T16:00:01+11:00 https://pharmadispatch.com/news/research-australia-calls-on-senate-to-scrap-rd-tax-changes 2018-11-08T16:00:01+11:00 https://pharmadispatch.com/news/department-calls-industry-pricing-forums 2018-11-08T16:00:01+11:00 https://pharmadispatch.com/news/is-this-a-system-that-weaponises-the-department-of-finance 2018-11-09T15:00:01+11:00 https://pharmadispatch.com/news/is-it-time-to-start-preparing-again 2018-11-09T15:00:01+11:00 https://pharmadispatch.com/news/melanoma-researchers-win-gsk-award-for-research-excellence 2018-11-09T15:00:01+11:00 https://pharmadispatch.com/news/new-leadership-for-otsuka-australia 2018-11-09T15:00:01+11:00 https://pharmadispatch.com/news/amgen-extends-science-program-to-australia 2018-11-09T15:00:01+11:00 https://pharmadispatch.com/news/bms-creates-magical-morning-for-camp-quality-kids 2018-11-09T15:00:01+11:00 https://pharmadispatch.com/news/could-this-gift-the-reform-pursued-since-1995 2018-11-12T16:00:01+11:00 https://pharmadispatch.com/news/these-are-the-examples-we-know-about-it 2018-11-12T16:00:01+11:00 https://pharmadispatch.com/news/the-incident-that-captures-the-risk 2018-11-12T16:00:01+11:00 https://pharmadispatch.com/news/patients-gather-for-healthevoices-conference 2018-11-12T16:00:01+11:00 https://pharmadispatch.com/news/compare-and-contrast-the-approach 2018-11-13T16:00:01+11:00 https://pharmadispatch.com/news/major-changes-for-bionomics 2018-11-13T16:00:01+11:00 https://pharmadispatch.com/news/new-study-backs-dpp-4-on-cv-risks 2018-11-13T16:00:01+11:00 https://pharmadispatch.com/news/survey-reveals-patient-practice-gap 2018-11-13T16:00:01+11:00 https://pharmadispatch.com/news/ex-ma-ceo-loses-preselection-battle 2018-11-13T16:00:01+11:00 https://pharmadispatch.com/news/government-confirms-savings-shortfall 2018-11-14T16:00:01+11:00 https://pharmadispatch.com/news/swisse-wins-china-brand-award 2018-11-14T16:00:01+11:00 https://pharmadispatch.com/news/senate-wants-government-response-on-cancer-report 2018-11-14T16:00:01+11:00 https://pharmadispatch.com/news/us-supply-to-pbs-a-factor-in-trade 2018-11-14T16:00:01+11:00 https://pharmadispatch.com/news/labor-moves-to-force-mhr-opt-out-extension 2018-11-14T16:00:01+11:00 https://pharmadispatch.com/news/industry-looks-for-protections-on-pathway-reforms 2018-11-15T16:00:01+11:00 https://pharmadispatch.com/news/mpa-meets-for-regular-catch-up 2018-11-15T16:00:01+11:00 https://pharmadispatch.com/news/government-extends-my-health-record-opt-out-period 2018-11-15T16:00:01+11:00 https://pharmadispatch.com/news/sa-recognition-for-novartis 2018-11-15T16:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-reports-new-positive-results-for-loxl2-program 2018-11-16T16:00:01+11:00 https://pharmadispatch.com/news/government-extends-cso-contracts-and-links-outcome-to-spa-change 2018-11-16T16:00:01+11:00 https://pharmadispatch.com/news/industry-executive-to-lead-anatara 2018-11-16T16:00:01+11:00 https://pharmadispatch.com/news/novartis-confirms-alcon-spinoff-details 2018-11-16T16:00:01+11:00 https://pharmadispatch.com/news/is-that-consulting-or-informing 2018-11-19T16:00:01+11:00 https://pharmadispatch.com/news/rva-welcomes-funding-for-rare-disease-framework 2018-11-19T16:00:01+11:00 https://pharmadispatch.com/news/allergan-partners-with-glaucoma-australia 2018-11-19T16:00:01+11:00 https://pharmadispatch.com/news/rd-tax-change-driven-by-savings-target 2018-11-19T16:00:01+11:00 https://pharmadispatch.com/news/government-tables-report-response 2018-11-19T16:00:01+11:00 https://pharmadispatch.com/news/escrow-model-most-likely-for-spa-reform 2018-11-20T16:00:01+11:00 https://pharmadispatch.com/news/what-are-these-unpublished-reviews 2018-11-20T16:00:01+11:00 https://pharmadispatch.com/news/dis-tops-200000-participants 2018-11-20T16:00:01+11:00 https://pharmadispatch.com/news/the-consequences-of-rd-tax-change-not-unintended 2018-11-21T16:00:01+11:00 https://pharmadispatch.com/news/are-new-therapeutic-groups-an-option 2018-11-21T16:00:01+11:00 https://pharmadispatch.com/news/more-confirmed-speakers-for-pharmadispatch-2019 2018-11-21T16:00:01+11:00 https://pharmadispatch.com/news/pharmacy-to-evolve-in-response-to-medicine-complexity 2018-11-21T16:00:01+11:00 https://pharmadispatch.com/news/therapeutic-groups-20-years-of-torment 2018-11-22T16:00:01+11:00 https://pharmadispatch.com/news/no-shortage-of-candidates-for-therapeutic-groups 2018-11-22T16:00:01+11:00 https://pharmadispatch.com/news/queensland-ms-cell-therapy-advances-in-trial 2018-11-22T16:00:01+11:00 https://pharmadispatch.com/news/could-this-be-the-new-norm 2018-11-22T16:00:01+11:00 https://pharmadispatch.com/news/spa-reform-could-push-pharma-into-financial-services 2018-11-23T16:00:01+11:00 https://pharmadispatch.com/news/pharmac-six-months-to-switch-to-biosimilar 2018-11-23T16:00:01+11:00 https://pharmadispatch.com/news/pharmacy-still-lags-natural-therapies 2018-11-23T16:00:01+11:00 https://pharmadispatch.com/news/pfizer-says-farewell-to-west-ryde 2018-11-23T16:00:01+11:00 https://pharmadispatch.com/news/clock-ticking-on-key-issues-as-election-rapidly-approaches 2018-11-26T16:00:01+11:00 https://pharmadispatch.com/news/in-the-end-will-the-government-just-want-savings 2018-11-26T16:00:01+11:00 https://pharmadispatch.com/news/government-receipts-continue-to-boom 2018-11-26T16:00:01+11:00 https://pharmadispatch.com/news/mixed-result-for-australia-in-new-innovation-report 2018-11-26T16:00:01+11:00 https://pharmadispatch.com/news/government-expands-access-to-continuous-glucose-monitoring-devic 2018-11-26T16:00:01+11:00 https://pharmadispatch.com/news/international-comparisons-not-so-easy-1 2018-11-27T16:00:01+11:00 https://pharmadispatch.com/news/biosimilars-competitive-forces-generally-act-more-slowly 2018-11-27T16:00:01+11:00 https://pharmadispatch.com/news/government-pushes-for-work-on-new-therapeutic-group-framework 2018-11-27T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-calls-hta-roundtable 2018-11-27T16:00:01+11:00 https://pharmadispatch.com/news/a-narrow-path-just-narrowed-further 2018-11-28T16:00:01+11:00 https://pharmadispatch.com/news/australian-company-updates-on-alzheimers-clinical-trial 2018-11-28T16:00:01+11:00 https://pharmadispatch.com/news/pm-drops-hint-on-agreement-extension 2018-11-28T16:00:01+11:00 https://pharmadispatch.com/news/zelda-partners-with-st-vincents-hospital-on-opioid-reduction-stu 2018-11-28T16:00:01+11:00 https://pharmadispatch.com/news/ten-pre-election-parliamentary-sitting-days 2018-11-28T19:40:01+11:00 https://pharmadispatch.com/news/more-discussion-is-only-leading-to-more-disagreement 2018-11-29T16:00:01+11:00 https://pharmadispatch.com/news/new-director-for-asmi 2018-11-29T16:00:01+11:00 https://pharmadispatch.com/news/other-groups-excluded-from-new-funding-agreements 2018-11-29T16:00:01+11:00 https://pharmadispatch.com/news/federal-court-backs-lundbeck-in-lexapro-case 2018-11-29T16:00:01+11:00 https://pharmadispatch.com/news/cso-review-no-ban-on-exclusive-direct-distribution 2018-11-30T16:00:01+11:00 https://pharmadispatch.com/news/agenda-confirmed-for-next-weeks-hta-roundtable 2018-11-30T16:00:01+11:00 https://pharmadispatch.com/news/a-landmark-moment-in-pbs-history 2018-11-30T16:00:01+11:00 https://pharmadispatch.com/news/first-recipient-of-the-macquarie-university-pharmaceutical-schol 2018-11-30T16:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-makes-cancer-medicines-the-focus-for-december 2018-11-30T16:00:01+11:00 https://pharmadispatch.com/news/gilead-announces-2019-fellowship-grants 2018-12-03T16:00:01+11:00 https://pharmadispatch.com/news/new-cso-guidelines-give-dhl-a-choice 2018-12-03T16:00:01+11:00 https://pharmadispatch.com/news/a-smart-move-that-appears-to-resolve-nothing 2018-12-03T16:00:01+11:00 https://pharmadispatch.com/news/what-is-the-cso-and-its-purpose 2018-12-03T16:00:01+11:00 https://pharmadispatch.com/news/labor-to-launch-root-and-branch-review-of-research 2018-12-03T16:00:01+11:00 https://pharmadispatch.com/news/abbvies-kirsten-odoherty-judge-people-on-output-not-attendance 2018-12-10T15:00:01+11:00 https://pharmadispatch.com/news/ma-hta-roundtable-an-important-conversation 2018-12-04T16:00:01+11:00 https://pharmadispatch.com/news/pfizer-recognised-for-corporate-volunteering-program 2018-12-04T16:00:01+11:00 https://pharmadispatch.com/news/sector-working-through-new-cso-details 2018-12-04T16:00:01+11:00 https://pharmadispatch.com/news/dhl-announces-new-partnership-with-chemist-warehouse 2018-12-04T16:00:01+11:00 https://pharmadispatch.com/news/change-on-the-way-for-department-of-health 2018-12-04T16:00:01+11:00 https://pharmadispatch.com/news/astrazeneca-to-scrap-exclusive-direct-distribution-model 2018-12-04T19:33:01+11:00 https://pharmadispatch.com/news/humira-deals-surprised-everyone-including-abbvie 2018-12-05T14:00:01+11:00 https://pharmadispatch.com/news/are-humira-deals-really-pay-for-delay 2018-12-05T14:00:01+11:00 https://pharmadispatch.com/news/ausbiotech-welcomes-delay-in-senate-report 2018-12-05T14:00:01+11:00 https://pharmadispatch.com/news/the-loss-of-exclusivity-and-assorted-patents 2018-12-05T14:00:01+11:00 https://pharmadispatch.com/news/new-stem-partnership-for-bayer 2018-12-05T14:00:01+11:00 https://pharmadispatch.com/news/global-hr-accreditation-for-australian-pharma-companies 2018-12-06T16:00:01+11:00 https://pharmadispatch.com/news/psa-welcomes-new-guidelines-but-cautions-on-exclusive-direct 2018-12-06T16:00:01+11:00 https://pharmadispatch.com/news/is-it-part-of-an-overarching-strategic-process 2018-12-06T16:00:01+11:00 https://pharmadispatch.com/news/pharmadispatch-2019-renewed-focus-on-supply-chain 2018-12-06T16:00:01+11:00 https://pharmadispatch.com/news/mtp-welcomes-new-government-funding 2018-12-06T16:00:01+11:00 https://pharmadispatch.com/news/hurdles-mount-for-supply-chain-payment-reform 2018-12-07T16:00:01+11:00 https://pharmadispatch.com/news/get-ready-for-2019-pharma-2-peak-kosi-challenge 2018-12-07T16:00:01+11:00 https://pharmadispatch.com/news/new-head-of-pbs-pricing-and-policy 2018-12-07T16:00:01+11:00 https://pharmadispatch.com/news/the-combined-view-smorgasboard 2018-12-07T16:00:01+11:00 https://pharmadispatch.com/news/the-facts-on-workplace-flexibility 2018-12-10T15:00:01+11:00 https://pharmadispatch.com/news/greg-hunt-welcomes-collaboration-on-flu-vaccine 2018-12-10T15:00:01+11:00 https://pharmadispatch.com/news/who-understands-and-will-pay-for-the-combined-view 2018-12-10T15:00:01+11:00 https://pharmadispatch.com/news/pfizer-officially-makes-sydney-cbd-its-new-home 2018-12-10T20:55:01+11:00 https://pharmadispatch.com/news/hitting-a-nerve-on-workplace-flexibility 2018-12-11T15:00:01+11:00 https://pharmadispatch.com/news/companies-share-their-approach-to-workplace-flexibility 2018-12-11T15:00:01+11:00 https://pharmadispatch.com/news/updated-healthcare-atlas-highlights-medicine-use 2018-12-11T15:00:01+11:00 https://pharmadispatch.com/news/melbourne-company-joins-antimicrobial-challenge 2018-12-11T15:00:01+11:00 https://pharmadispatch.com/news/bridge-program-participants-visit-us-based-companies 2018-12-12T16:00:01+11:00 https://pharmadispatch.com/news/tga-approves-new-opdivo-dosing-schedule 2018-12-12T16:00:01+11:00 https://pharmadispatch.com/news/insurers-use-pbs-as-model-for-devices 2018-12-13T16:00:01+11:00 https://pharmadispatch.com/news/australia-delivers-world-first-for-new-cancer-therapy 2018-12-12T16:00:01+11:00 https://pharmadispatch.com/news/exclusive-pbac-targets-lung-cancer-in-first-pan-tumour-outcome 2018-12-12T05:47:01+11:00 https://pharmadispatch.com/news/bayer-backing-new-kidney-disease-trial 2018-12-13T16:00:01+11:00 https://pharmadispatch.com/news/100000-the-goal-for-pharmacup19 2018-12-13T16:00:01+11:00 https://pharmadispatch.com/news/industry-and-stakeholders-working-through-pan-tumour-response 2018-12-13T16:00:01+11:00 https://pharmadispatch.com/news/new-national-president-for-psa 2018-12-13T16:00:01+11:00 https://pharmadispatch.com/news/digital-partnership-for-gsk-consumer-health 2018-12-13T16:00:01+11:00 https://pharmadispatch.com/news/msd-cautions-on-first-pan-tumour-outcome 2018-12-13T16:00:01+11:00 https://pharmadispatch.com/news/february-push-would-avoid-parliamentary-scrutiny 2018-12-14T16:00:01+11:00 https://pharmadispatch.com/news/new-health-program-highlights-pbs-challenge 2018-12-14T16:00:01+11:00 https://pharmadispatch.com/news/pharmaxis-reports-first-us-sales-of-aridol 2018-12-14T16:00:01+11:00 https://pharmadispatch.com/news/api-moves-on-sigma 2018-12-14T21:10:01+11:00 https://pharmadispatch.com/news/andrew-wilson-good-things-need-to-be-noted 2018-12-17T16:00:01+11:00 https://pharmadispatch.com/news/andrew-wilson-it-is-no-longer-just-about-medicines 2018-12-18T15:00:01+11:00 https://pharmadispatch.com/news/the-mystery-deepens-on-pdl1-and-lung-cancer 2018-12-17T16:00:01+11:00 https://pharmadispatch.com/news/outcomes-suggest-another-look-at-biosimilar-policy 2018-12-17T16:00:01+11:00 https://pharmadispatch.com/news/november-pbac-outcomes 2018-12-17T16:00:01+11:00 https://pharmadispatch.com/news/april-2019-price-reductions 2018-12-17T16:00:01+11:00 https://pharmadispatch.com/news/the-complex-parliamentary-approval-process 2018-12-18T15:01:01+11:00 https://pharmadispatch.com/news/myefo-government-funds-itself-on-supply-chain-reform 2018-12-17T21:06:01+11:00 https://pharmadispatch.com/news/pbs-missing-out-on-budget-windfall 2018-12-18T15:00:01+11:00 https://pharmadispatch.com/news/a-new-home-for-medicines-australia 2018-12-18T15:00:01+11:00 https://pharmadispatch.com/news/tga-approves-first-car-t-therapy 2018-12-19T16:00:01+11:00 https://pharmadispatch.com/news/labor-to-preserve-rd-tax-incentive 2018-12-19T16:01:01+11:00 https://pharmadispatch.com/news/a-new-future-for-medical-research-funding 2018-12-18T16:00:01+11:00 https://pharmadispatch.com/news/new-fees-a-pbs-listing-tax 2018-12-20T16:00:01+11:00 https://pharmadispatch.com/news/unresolved-issues-will-make-for-an-even-tougher-2019 2018-12-20T16:00:01+11:00 https://pharmadispatch.com/news/supply-chain-payment-reform-unlikely-in-2019 2018-12-20T16:00:01+11:00 https://pharmadispatch.com/news/gsk-and-pfizer-merge-consumer-health-businesses 2018-12-20T16:00:01+11:00 https://pharmadispatch.com/news/biosimilars-feature-on-march-pbac-agenda 2018-12-20T16:00:01+11:00